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Science is a partial means to the understanding of the ultimate 
question of life, the universe, and everything. 
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INTRODUCTION 
This dissertation is a study of the effects of pyridonecarboxylic 
acid derivatives (quinolones) on Pseudomonas aeruginosa. These drugs 
are important to study because the newer, more potent derivatives are 
effective against gram negative infections (30,34) such as f. aeruginosa 
which is an opportunistic pathogen of burn wounds and the lungs of 
children with cystic fibrosis (2,13,14,32,66). Norfloxacin, a newer 
derivative, which is more potent than oxolinic acid and nalidixic acid, 
has not yet been studied in P. aeruginosa. Since the effects of 
oxolinic acid and nalidixic acid on Escherichia coli have been well 
studied (e.g., 19), it is beneficial to compare the effects of 
norfloxacin, oxolinic acid, and nalidixic acid on P. aeruginosa. 
Pyridonecarboxylic acids act by binding to DNA (70) and inhibiting 
the activities of DNA gyrase and of one of its two subunits (termed A) 
which also interacts with another protein to form Topo II' (6). 
Therefore, in order to understand the mechanism of drug action, the in 
vitro effects of these derivatives on P. aeruginosa DNA gyrase and its A 
subunit will be studied. 
1 
REVIEW OF THE RELATED LITERATURE 
SUPERHELICAL DNA 
The bacterial chromosome consists of a closed circular double helix 
of DNA that is maintained in an underwound topological state. The 
twisting of the DNA helix either into an underwound or an overwound 
state is termed negative supercoiling or positive supercoiling, 
respectively. The degree of supercoiling is described by the following 
relationship: 
T=L-L0 1. 
where T is the number of titratable superhelical turns, L is the number 
of times that one strand of the double helix crosses over the other 
strand, termed the linking number, and L0 is the linking number of 
relaxed (not twisted) DNA. 
In nature, DNA is found in a negatively supercoiled state (L<L0) 
which promotes single strandedness. This negative superhelicity has 
been shown to be required for replication, transcription, recombination, 
repair of DNA, and plasmid maintenance (reviewed in 10, 24, and 85). 
Positively supercoiled DNA (L>L0) can be generated in vitro, however no 
biological significance has been found for overwound DNA. 
2 
DNA TOPOISOMERASES 
How does the chromosome become negatively supercoiled? 
Environmental parameters such as ionic strength, temperature, and the 
concentrations of certain DNA binding ligands affect the number of 
primary twists per DNA molecule. Therefore, the value of L0 in equation 
1 will vary depending on the environmental conditions in which the DNA 
is formed (reviewed in 18). 
The other factor that determines superhelicity of DNA is the 
concerted activity of a class of enzymes termed DNA topoisomerases. 
Topoisomerase I relaxes negative supercoils by breaking one strand of 
the duplex and releasing one supercoil (L) at a time. Topoisomerase II 
(DNA gyrase) supercoils the chromosome by binding DNA at two places, 
breaking both strands of one of the bound portions and passing the other 
bound portion through the break (Figure 1), thus decreasing L by two for 
each reaction (24). 
The activities of topoisomerases I and II in the cell are balanced 
to maintain an optimal level of superhelicity of the chromosome. 
Mutations in Escherichia coli topoisomerase I result in an increase in 
negative superhelical density in both the bacterial chromosome and 
plasmid pBR322. Some strains containing topoisomerase I mutations, 
however, have decreased negative superhelical density. These mutants 
have developed secondary mutations in DNA gyrase that compensate for the 
pres~mably intolerable level of superhelical density caused by the 
deficiency in topoisomerase I (66). 
The homeostatic control of DNA supercoiling by topoisomerase I and 
DNA gyrase regulates the expression of the f. coli DNA gyrase gene. 
0 
DNA gyrase binds better to relaxed DNA 
than it does to supercoiled DNA. 
4 
The DNA wraps around DNA gyrase in a 
positive (+) sense creating negative 
(-) supercoild elsewhere in the DNA. 
DNA gyrase reseals the break 
on the front side. 
DNA gyrase makes a double-stranded 
break in the back segment. 
Figure 1. The Supercoiling Reaction of DNA Gyrase 
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Addition of exogenous topoisomerase I to an S-30 in vitro protein 
synthesizing system stimulates synthesis of DNA gyrase (52). This 
stimulation is probably due to a decrease in the negative superhelical 
density and not to any direct role of £_. coli topoisomerase I as a 
regulatory protein, since addition of exogenous Hela cell topoisomerase 
I (a eukaryotic enzyme) to this system also stimulates DNA gyrase 
synthesis (52). Treatments that block DNA gyrase activity and decrease 
the superhelical density of intracellular DNA result in as much as a 
10-fold increase in the in vivo synthesis of both the A and B subunits 
of DNA gyrase (52). Thus, relaxation of the chromosome stimulates the 
synthesis of DNA gyrase and results in an increased capability of the 
cell to supercoil DNA. Conversely, increasing the superhelical density 
of the chromosome decreases the synthesis of DNA gyrase and results in a 
decreased capability of the cell to supercoil DNA. It is not known if 
the expression of the topoisomerase I gene is affected by the degree of 
supercoiling as well. 
DNA gyrase is made up of two subunits (A and B) which map 
separately on the E. coli chromosome (29,62). The holoenzyme, which has 
a molecular weight of 400,000, consists of two A subunits (MW 105,000) 
and two B subunits (MW 95,000) (29,62). In vitro there are seven 
- ---
different reactions catalyzed by DNA gyrase as a holoenzyme or by one of 
the subunits alone (Figure 2): 
1. Both subunits are required for negative supercoiling of a 
closed DNA duplex in a processive reaction that required ATP and 
Mg++, and that is stimulated by spermidine (10,21,22,29). 
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1. 0 ATP 
Gyrase 
2. ~ 0 
3.. D N A+Gyrase DNA·Gyrase 
4. oxo , 
Gyrase NaDodSO~ 
Duplex DNA 
5. ATP ADP + Pi 
Spermidine. 
6. ~ ~ J!TP+Gyrase 
7. oovo ~ T P+.Gyrase 
Figure 2. The Activities of DNA Gyrase. 
The reactions illustrated are supercoiling (reaction 1), relaxation 
(reaction 2), binding (reaction 3), cleavage (reaction 4), ATPase 
(reaction 5), catenation and decatenation (reaction 6), and knotting and 
unkotting (reaction 7). The DNA substrate is shown as relaxed, closed 
circular DNA for reaction 1, negatively supercoiled DNA for reaction 2, 
6, and 7, and as linear DNA for reaction 4. Oxolinic acid is 
abbreviated OXO and sodium dodecyl sulfate as NaDodS04. 
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2. The A subunit will relax negatively supercoiled ONA in the 
absence of ATP (22,23,46,77). In the presence of oxolinic acid (an 
inhibitor of the A subunit), ~ less that one percent of the 
supercoiling reaction products consists of cleaved linear ONA (77). 
3. The ho l oenzyme binds to ONA about every 100 k i l obase pairs. 
About 140 base pairs of ONA wrap around the outside of the enzyme 
in a positive coil creating counterposing negative supercoils 
elsewhere in the ONA (29,39,62). DNA gyrase binds better to 
relaxed DNA than it does to supercoiled DNA (10). Using electron 
microscopy, the A subunit has been visualized to bind to DNA in the 
absence of the B subunit (62). Electron micrographs of ONA gyrase 
from M. luteus shadowed with platinum show a heart shaped molecule. 
When these molecules are complexed with ONA, two binding modes are 
observed, one in which the 1 ength of the bound ONA is shortened, 
termed the full binding mode, and a second in which the length of 
the bound DNA is unaltered, termed the incomplete binding mode 
{38). 
4. The ho 1 oenzyme cl eaves the ONA by forming a phosphotyros i ne 
bond between the 5'-hydroxyl of each strand and the A subunit (79). 
This can be seen in vitro by incubating DNA gyrase and DNA with 
oxolinic acid, followed by treatment with sodium dodecyl sulfate 
(SOS). Cleavage is observed in the absence of SOS, but SOS 
treatment increases the fraction of cleaved molecules from less 
than one percent to 41 percent. The same pattern of cleavage is 
observed when ONA gyrase isolated from£. coli, Micrococcus luteus, 
Bacillus subtilis, or a combination of subunits from~· coli and~· 
8 
luteus is used (6,61,76,77). ATP alters the cleavage pattern by 
stimulating cleavage at some sites and reducing it at others (77). 
5. The B subunit hydrolyzes ATP into ADP and Pi in the presence of 
duplex DNA (58,77). 
6. The holoenzyme can catenate and decatenate DNA rings in the 
presence of ATP. Catenation requires spermidine and decatenation 
requires the absence of spermidine (2). 
7. The holoenzyme can also unknot and knot DNA in the presence of 
ATP ( 10,43). 
The subunits of DNA gyrase are most likely in equilibrium with the 
complete protein, since the addition of the A subunit to DNA gyrase 
stimulates its supercoiling activity and addition of drug resistant A 
subunit to DNA gyrase renders the supercoiling activity resistant to the 
drug. 
TOPO II I 
The A subunit of DNA gyrase can also bind with another protein, 
termed v, to form topo II'. The v subunit which consists of a single 
50,000 dalton polypeptide appears to be a proteolytic product of the B 
subunit, since their polypeptide maps show substantial similarity (6). 
Topo II' has three activities in common with DNA gyrase; relaxation of 
negative supercoils, wrapping of the DNA substrate around it in a 
positive coil, and cleavage of DNA at specific sites in the presence of 
oxolinic acid (reference 4, and activities 2, 3, and 4 from the previous 
section). Although the cleavage patterns of topo II' and DNA gyrase are 
the same, topo !I's pattern is not altered by ATP as is the pattern of 
9 
DNA gyrase (6,77). Topo II' possesses one activity that DNA gyrase 
lacks; it will relax positive supercoils. This activity does not 
require ATP. Neither subunit A or v by themselves will relax positive 
supercoils (6). It appears that subunit v results from the cleavage of 
the portion of the B subunit that contains the ATPase activity. 
Brown et~· (6) noticed that DNA relaxed by topo II' has a higher 
electrophoretic mobility than DNA gyrase-relaxed DNA. This increased 
mobility is due to positive supercoils present in the topo II' relaxed 
DNA to an extent depending stoichiometrically on the ratio of enzyme to 
DNA. They suggest that the reason for this is that topo II', like DNA 
gyrase, wraps the DNA substrate around itself in a positive coil which 
creates counterposing negative supercoils elsewhere in the DNA. Topo 
II' unlike DNA gyrase will relax these negative supercoils, leaving 
positively supercoiled DNA. 
It is suspected that 1 ess pure preparations of DNA gyrase are 
contaminated with this relaxing enzyme, because as the purity of DNA 
gyrase is increased, the ratio of oxolinic acid-sensitive relaxation 
activity to oxolinic acid-sensitive supercoiling activity declines to a 
nonzero plateau value (29,62,77; i.e., there is an excess of relaxation 
activity over supercoiling activity). The contaminating relaxing 
activity cannot be due to topoisomerase I, since this enzyme is not 
sensitive to oxolinic acid (24). Since topo II' can relax positive 
supercoils, the ability of less pure DNA gyrase preparations to relax 
positive supercoils (22,77) and the disappearance of this activity upon 
further purification (6) can be explained. 
There are three known f. coli topoisomerases (compared in table 1): 
topoisomerase I, topoisomerase II (DNA gyrase}, and topoisomerase II'. 
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Table 1. ~· coli Topoisomerases 
Property Topo I (w) Topo II ( gyrase) Topo II I 
Subunits Monomer A B A v 
Proto~er Mw. 110 105 95 105 50 (x 10 ) 
Structural Unknown ~ ~ ~ ~? gene 
Activities: 
Relaxation of Yes Yes Yes (-) Supercoils 
Relaxation of No No Yes 
(+) Supercoils 
Introduction of No Yes No (-) Supercoil s 
Stoichiometric No No Yes 
( +) Supercoi 1 
Introduction 
DNA Wrapping None (+) ( +) 
around Enzyme 
DNA Site- Some Yes Yes 
specific Binding 
Dena tu rant- Single- Double- Double-
induced DNA strand strand strand 
breaks 
11 
All relax negative supercoils, with topoisomerase I possessing the 
greatest total detectable activity, topo II' the next most, and DNA 
gyrase the least (6). Only DNA gyrase can negatively supercoil DNA, and 
only topo II' can relax positively supercoiled DNA (6). 
ANTIBIOTICS THAT AFFECT DNA GYRASE AND TOPO II' 
The activities of the B subunit are inhibited by coumermycin Al and 
novobiocin (reviewed in 20 and 24). These antibiotics cause a reduction 
in the superhelical density that closely parallels an inhibition of DNA 
synthesis, i ndi ca ting that the decrease causes the i nhi bi tion of DNA 
syn thesis (16). 
Pyridonecarboxylic acid derivatives (e.g., nalidixic acid, oxolinic 
acid, and norfloxacin, Figure 3) are antimicrobial drugs effective 
against most gram negative bacteria. These drugs inhibit DNA synthesis 
by inhibiting the activities of the A subunit (10). This inhibition is 
readily reversed by removal of the drug. Engle et 2l_. (19) have 
suggested that these drugs inhibit DNA replication by forming a tight 
complex between the A subunit and DNA which inhibits replication fork 
migration. Upon treatment with the drug, there is an immediate 
inhibition of DNA synthesis. Recovery synthesis following inhibition is 
possible in wild type strains of E. coli but not in mutants deficient in 
recombinational repair of DNA (19). 
Recent evidence shows that pyridonecarboxylic acids bind to DNA and 
not the DNA gyrase (70). They bind preferentially to single-stranded 
DNA rather than the double-stranded DNA. The calculated apparent Kd 
values of the different derivatives correlate well with their Ki values 
0 
COOH 
Nalidixic Acid 
Mw. 232.2 
Norfl oxaci n 
Mw. 319.33 
0 
Oxolinic Acid 
Mw. 261 
CO)H 
Figure 3. The Chemical Structures of Pyridonecarboxylic Acid Derivatives. 
..... 
N 
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(i.e., the more potent the inhibitor, the greater it binds to DNA). 
Shen et ~· (70) proposed that DNA gyrase translocates along the DNA or 
DNA segments translocate through gyrase until the DNA gyrase comes to 
the bound drug molecule and forms a ternary complex that is more stable 
than the binary DNA gyrase-DNA complex. 
Inhibition of DNA synthesis in ~· coli by pyridonecarboxylic acids 
has been shown to have biphasic kinetics in the absence of DNA repair or 
initiation of new rounds of DNA replication (17). There is an initial 
rapid rate of inhibition followed by a slower rate of inhibition. If 
the drug-DNA gyrase complexes occurred only at 100 kbp intervals, then 
monophasic kinetics would be expected. The fact that oxolinic acid and 
SOS treatment induces additional cleavage in pulse-labeled DNA as 
opposed to long term-labeled DNA (17), indicates that DNA gyrase binds 
at or near the replication fork in addition to its binding at about 100 
kbp intervals. The initial rapid inhibition observed in 
pyridonecarboxylic acid treated E. coli cells may be due to inactivation 
of gyrase at or near the replication forks. Some replication forks may 
have escaped the drug and the second slower rate of inhibition may be 
due to these replication forks proceeding to the terminus of 
replication. Increasing the number of inactivated DNA gyrase sites by 
increasing the concentration of pyridonecarboxylic acids causes an 
increase in the initial rapid rate of inhibition but does not change the 
slower rate of inhibition (17). This suggests that the replication 
forks are not stopped by drug-DNA gyrase complexes located at 100 kbp 
intervals (17) • 
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DNA REPAIR AND RECOVERY SYNTHESIS IN E. COLI 
There are four DNA repair pathways known to exist in~· coli (82). 
These pathways are called photoreactivation, SOS processing, excision 
repair, and postreplication recombination (Table 2). 
Photoreactivation specifically repairs the most common effect of 
ultraviolet irradiation on DNA, the thymine dimer. A thymine dimer, 
results from the covalent cross-linking of two thymine bases located 
adjacent to each other on the same strand of DNA. The photoreactivation 
enzyme binds to a dimer and directly cleaves the crosslink in a 
light-dependent reaction (82). Therefore, in order to study the other 
three DNA repair pathways without interference of photoreactivation, 
experiments must be conducted in the dark. 
The three dark repair pathways have the recA gene in common. The 
product of the recA gene is a protein that regulates the expression of 
SOS processing and one of the two modes of excision repair. It is also 
an integral part of recombinational repair. A double mutant deficient 
in both excision repair and the recA function has virtually no DNA 
repair capacity in the absence of visible light (82). 
SOS processing is part of the SOS response that occurs when the 
protease activity of recA protein is induced by a DNA damaging agent 
such as ultraviolet light or nalidixic acid. The recA protease acts by 
cleaving a repressor protein coded for by the lexA gene. This lexA 
repressor binds to the control regions of the genes involved in the SOS 
response (Table 2) and prevents their expression. Cleavage of the lexA 
repress or by the recA protein allows the expression of the SOS genes 
until the DNA damaging signal is gone and the recA protease function is 
Table 2. The Genes Involved in the SOS Response 
DNA Repair E. coli Removes Replication Inducible Mutagenic 
Pathways -Genes Lesions Dependent 
Photoreactivation phr Yes No No No 
Excision Repair uvrA, uvrB, Yes No Yes* No 
uvrC, uvrE 
Postreplication recA, recB, No Yes Yes No 
Recombination recC, sbcB, 
sbcB, recE, 
recF, recJ, 
recK 
SOS Processing umuC, umuD, No Yes Yes Yes 
lon, mut, 
dam, 1 exA 
*The short patch repair mode is constitutive. 
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no longer active. Not much is known about the SOS processing repair 
pathway except that it is error-prone {or mutagenic) and that it occurs 
during replication. It appears that during replications, SOS processing 
functions will pair any base with a damaged base. Since there is a 
three out of four chance that the wrong base will be paired with the 
damaged base, mutations will result from this type of repair (82). 
The excision repair pathway repairs DNA by removing a portion of 
the strand of DNA that contains the damage. Ninety nine percent of the 
time, a section of approximately 20 bases is cleaved in the short patch 
repair mode, which is a constitutive function of the cell. In the other 
one percent of the time, a section of about 1500 bases will be cleaved 
in long patch repair, a mode which must be induced by the recA protease. 
This repair must occur before replication can continue since the damage 
poses as a barrier to the migration of the replication fork (79). 
Postreplication recombination is useful when the cell has acquired 
a large amount of damage and does not have enough time to repair the DNA 
before replication has to be completed. DNA polymerase will bypass the 
damage and leave a gap in the complementary strand. The damage and 
resulting gap will be repaired later when the cell has the time and 
energy. The gap is filled with a strand from the complementary DNA 
molecule, leaving one molecule with the damage and the other with a gap. 
Now each DNA molecule has one good strand that can be used as a template 
for synthesizing a complementary strand (82). 
The recovery syn thesis seen in E_. col i after i nh i bit ion of DNA 
synthesis by pyridonecarboxylic acid derivatives is not affected by 
mutations that render the cell deficient in excision repair (19). 
Recovery synthesis does not occur in mutants with defects in the recA or 
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lexA genes (19). Since the short patch repair mode of excision repair 
is not regulated by the recA protein (82), and since the drug-DNA gyrase 
complex is longer than twenty nucleotides (the length of DNA excised in 
the short patch repair mode), the short patch repair mode can be ruled 
out as the repair process used to remove the drug-DNA gyrase complex. 
Nalidixic acid has been shown to induce protein X, which has been 
identified as the protein product of the E. coli recA gene 
(25,26,29,30). It also has been shown to induce error-prone repair of 
UV-irradiated phage 9}X174 DNA in~· coli (67). However, little or no 
induction of recA occurs at low concentrations of oxolinic acid where 
inhibition and recovery synthesis still occur (19). Perhaps there are 
enough low constitutive levels of recA protein present in the wild type 
cell to remove the drug-DNA gyrase complex from the DNA. The exact DNA 
repair mechanism that ~· coli uses to recover from inhibition of DNA 
synthesis by pyridonecarboxylic acid derivatives is still unknown. 
BACTERICIDAL ACTIVITY OF PYRIDONECARBOXYLIC ACID DERIVATIVES 
Inhibition of DNA synthesis may not be the cause of death in cells 
treated with pyridonecarboxylic acid derivatives. Optimal bactericidal 
concentrations of these drugs cause almost 100% inhibition of DNA 
synthesis but still allows some RNA and protein synthesis to occur (76). 
At higher concentrations, RNA and protein synthesis are inhibited to a 
greater extent and the drug is no longer as potent. Competent RNA and 
protein synthesis are required for killing, since their inhibition will 
reverse the bactericidal effects of pyridonecarboxyl ic acids (76,83). 
These results have led Stevens (76) to propose that the mechanism of 
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drug-induced death was due to an imba 1 ance between DNA and protein 
biosynthesis which leads to filamentation. This drug-induced 
filamentation results from the growth of the cell due to continued RNA 
and protein synthesis when cell division is inhibited due to inhibition 
of DNA replication. In support of this model, he noted that drug 
resistant mutants did not experience inhibition of DNA synthesis until 
high enough concentrations of the drug that RNA and protein synthesis 
were also inhibited. He also noted that cell death may be due to a more 
specific event since hydroxyurea also induces filamentation by 
inhibiting DNA synthesis while allowing RNA and protein synthesis to 
continue but does not cause cell death (76). 
Additional research has also suggested that the mechanism of 
drug-induced cell death may be more complex. A norfloxacin treated 
culture of logarithmically growing~· coli cells will almost immediately 
lose their viability, but some will grow and divide, while others will 
filament (11). This lethal unbalanced growth could result from the 
prevention of the completion of a round of chromosome replication by 
norfloxacin, since a round of chromosome replication may trigger the 
initiation of septation which precedes cell division (15). Lethal 
unbalanced growth is also seen in !!_. subtilis cells during thymine 
starvation or treatment with ionizing radiation (5). These treatments 
inhibit DNA replication but do not inhibit RNA or protein synthesis (5). 
Several laboratories have shown that inhibition of DNA gyrase 
causes differential effects on specific gene expression (summarized in 
table 1 or reference 18). The differential effects on gene expression 
may be the actual cause of drug-induced death. For instance, inhibiting 
DNA gyrase results in a decrease in the synthesis of outer membrane 
19 
proteins as opposed to inner membrane proteins (28). The rate of 
synthesis of inner membrane proteins increases exponentially throughout 
the cell cycle (63,64). The rate of synthesis of the outer membrane 
proteins is constant in the early part of the cell cycle, but doubles 
abruptly just before cell division (63,64). It has been proposed that 
this abrupt increase might be sufficient to initiate surface 
invagination and trigger septum formation and cell division (63,64). 
Therefore, by inhibiting the expression of outer membrane proteins, 
pyridonecarboxylic acid derivatives may prevent cell division. 
DNA GYRASE AND GENE EXPRESSION 
Genes coding for membrane proteins are not the only ones affected 
when DNA gyrase is inhibited. Inhibition of gyrase with nalidixic acid 
causes a decrease in expression of catabolite-regulated operons (66). 
A catabolite-regulated operon in E. coli is one that is turned off 
when glucose is present in the medium. ~· coli metabolizes glucose in 
preference to other sugars such as lactose, galactose, and arabinose. 
In the presence of glucose, ~· coli will repress the expression of the 
operons that code for the enzymes that metabolize these other sugars. 
The binding of a protein termed catabolite activator protein (CAP) to 
the control region of catabolite-regulated operons is required for their 
expression. The CAP protein, in turn, must interact with eye 1 i c AMP 
(cAMP) to be able to bind to DNA. Glucose prevents the expression of 
catabolite-regulated operons by reducing the levels of cAMP in the cell. 
The reduction in expression of catabolite-regulated operons by nalidixic 
acid does not seem to be mediated through alterations of the cAMP 
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concentrations in the cell, since addition of exogenous cAMP does not 
reverse the effects of nalidixic acid (71). 
The more sensitive an operon is to catabolite repression, the more 
its expression is reduced in the presence of nalidixic acid. The 
express ion of the tryptophanase gene and the three maltose operons, 
which are all very sensitive to catabolite repression, is also strongly 
inhibited by nalidixic acid, whereas the lactose operon displays a lower 
sensitivity to both catabolite repression and nalidixic acid. The 
threonine and tryptophan operons, which are insensitive to catabolite 
repression, are also insensitive to nalidixic acid (68). 
Smith et ~· (73) found that expression of the tryptophan operon is 
inhibited by novobiocin and nalidixic acid when it is under the control 
of the lambda phage PL promoter, but not when it is under the control of 
its own promoter. Transcription from PL is inhibited by phage repressor 
(71). This is another instance where an operon whose transcription is 
affected by a regulatory protein is repressed by nalidixic acid, while 
an operon whose transcript ion is unaffected by regulatory proteins is 
not repressed by nalidixic acid. 
Genes under the control of the tryptophan promoter require coupling 
between the translational machinery and RNA polymerase for continued 
transcription, while genes under the control of the PL promoter do not 
require this coupling (33). This indicates that there may be a 
relationship between the repression of a gene by pyridonecarboxylic 
acids and how closely it is coupled to translation. 
Novobiocin and pyridonecarboxylic acids have been shown to have a 
similar effect on transcription from specific operons (69,72,85), but 
they have different effects on the synthesis of the protein products of 
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these specific operons (81). In B. subtilis, novobiocin greatly 
inhibits the synthesis of alkaline phosphatase and histidase. It 
inhibits the synthesis of protease to a lesser extent and has no effect 
on amylase synthesis (81), whereas, pyridonecarboxyl ic acid severely 
inhibits only alkaline phosphatase synthesis (81). This difference 
between the two types of drugs indicates that they may effect gene 
expression through different mechanisms. 
The selective inhibition of gene expression by novobiocin and 
coumermycin Al is most likely a result of the decrease in negative 
superhelical density caused by these drugs (37). As was mentioned 
earlier, decreasing the superhelical density of the ~· coli chromosome 
by addition of exogenous topoisomerase I will stimulate the expression 
of the DNA gyrase gene in vitro (52). DNA gyrase synthesis can also be 
stimulated up to 10-fold by treatment with coumermycin Al or novobiocin, 
which block DNA gyrase activity and decrease the supercoiling of 
intracellular DNA (52). It appears that changing the degree of 
supercoiling by inhibiting DNA gyrase will have a positive effect on the 
expression of some genes and a negative effect on others. The change in 
superhelical density may alter the shape of binding sites of regulator 
proteins, such as contra 1 regions and promoters, and thus a 1 ter the 
affinity of the control proteins, such as CAP and RNA polymerase, for 
these sites. 
Pyridonecarboxylic acid derivatives may effect gene expression 
through a different mechanism, because the reduction of gene expression 
by oxolinic acid does not parallel the decrease in superhelical density 
caused by the drug (51). The selective inhibition of gene expression 
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may be caused by the drug-DNA gyrase complexes spread throughout the 
genome (74). 
PSEUDOMONAS AERUGINOSA DNA GYRASE AND TOPO II' 
P. aeruginosa is not inhibited by most pyridonecarboxyl ic acids 
(34), and DNA gyrase from f. aeruginosa is more resistant to inhibition 
by nalidixic acid than is gyrase from £_. coli (56). Norfloxacin, 
however, has been shown to be an effective antimicrobial agent against 
f. aeruginosa (30,34). In general, norfloxacin is more potent and acts 
against a broader spectrum of bacteria than other pyridonecarboxyl ic 
acids (30,34). Also, norfloxacin treatment reduces the amount of 
enterotoxin transported into the periplasm of £_. coli cells (11). 
Often, the symptoms of patients with bacterial infections are caused by 
specific proteins such as enterotoxin, which are excreted by the 
invasive bacteria. Therefore, norfloxacin may also have a value in the 
symptomatic relief of patients. 
In this dissertation, norfloxacin will be studied and compared to 
other pyridonecarboxylic acid derivatives. Previous studies with 
pyridonecarboxylic acid derivatives have dealt mostly with£_. coli, a 
bacterium commonly found in the human gut. This dissertation will deal 
with f. aeruginosa, a soil bacterium that has been increasingly detected 
as an opportunistic pathogen in patients suffering from trauma (2), 
burns (14), and cystic fibrosis (13,14,31,32). The A subunit of DNA 
gyrase and topo II' from ~· coli has been very well characterized 
(10,16,17,18,20,21,22,23,24,29,37,39,43,48,49,52,58,59,60,61,62,75,77} 
while little is known about P. aeruginosa A subunit (56). 
METHODS 
STRAINS AND MEDIA 
All strains (Table 3) have been derived from the prototrophic 
strain PAOl (67), and were maintained in Luria broth (55). Rec- strains 
are deficient in recombinational repair and Les- strains are deficient 
in prophage lysogeny establishment (Table 3). The norfloxacin resistant 
strains are spontaneous mutants (i.e., not exposed to mutagens). They 
were isolated by incubating strain RM9 in 10 tubes containing high 
concentrations of norfloxacin. One clone was isolated out of each of 
the four tubes exhibiting growth. f· coli DNA gyrase was isolated from 
strain H560 (polA, endA) which was a gift from Dr. Martin Gellert (22). 
All experiments were carried out in Pseudomonas Minimal Medium (57) 
containing 0.4% glucose and 0.01% arginine. All drugs were freshly 
prepared from each experiment at 100-fold greater than the desired final 
concentration. Norfloxacin (gift of Merck, Sharp, and Dohme), nalidixic 
acid (Sigma), and oxolinic acid (Sigma) were dissolved in .01 N NaOH and 
novobiocin in water. Chloramphenicol and rifamycin were dissolved in 
ethanol. Phage D3 and plasmid pME299 were gifts from Dr. Bruce W. 
Holloway and Dr. Dieter Haas, respectively. 9'X174 was purchased from 
Amersham. 
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Table 3. P. aeruginosa Strains Used in This Study 
Strain Genotype Relevant Phenotypes 
PA0303 argB21 Rec + 
RMB argB21, lesB908 Rec -
PA02001 arg-32, spr-39 Rec + 
PA02003 arg-32, spr-39, Rec 
and rec-1 
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MIC'S AND MBC'S 
The minimal inhibitory concentrations (MIC's) and minimal 
bactericidal concentrations (MBC's) were determined as follows. A 
series of test tubes containing varying concentrations of antibiotic in 
Mueller-Hinton broth were inoculated with 106 bacteria per ml and 
incubated at 37° C. The minimum concentration at which growth visible 
with the naked eye could be seen after 23 hours was designated the MIC. 
One hundred microliters of each culture which exhibited no visible 
growth was plated out in triplicate and incubated at 37° C for 23 hours. 
The concentration which allowed no growth on the plates was designated 
the MBC. 
RATE OF PROTEIN SYNTHESIS 
A growing culture of bacteria in early log phase was treated with 
antibiotic(s) (norfloxacin, nalidixic acid, and/or chloramphenicol). 
The rate of DNA or protein synthesis was determined by a modification of 
the method of Engle et tl· {19). A flask containing 60 ml of Luria 
broth was inoculated with f. aeruginosa to 9 Klett units (OD660 ) and 
incubated in a 37° C water bath with shaking until the culture grew to 
20 Klett units (early log phase). The culture was then split into three 
flasks (20 ml each), one of which was treated with norfloxacin, another 
with nalidixic acid, and tpe other with buffer containing no drug (100 
microliters of .01 N NaOH). At various times, 0.2 ml samples were 
removed and protein labeled with L-[4,5-3H]-leucine (1 microcurie/ml). 
After 4 minutes, NaOH (final concentration 0.3 N) and EDTA (final 
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concentration 0 .1%) was added. The protein was prec i pi ta ted with 40 
micrograms/ml of bovine serum albumin (BSA) and five percent 
trichloroacetic acid (final concentrations). The protein precipitates 
were collected on nitrocellulose filters, and counted in a Beckman LS 
7500 scintillation counter. 
RATE OF DNA SYNTHESIS 
The rate of DNA synthesis was measured in the same way that the 
rate of protein synthesis was measured except that [3H]-adenine (1 
microcurie/ml) was used and RNA was hydrolyzed by incubating the samples 
at 37° C overnight. 
KILLING EFFECTS OF ANTIBIOTICS 
A growing culture of bacteria in early log phase was divided into 
several aliquots and added to flasks containing various combinations of 
antibiotics (2700 micrograms/ml nalidixic acid, 16 micrograms/ml 
norfl oxac in, 100 micrograms/ml rifamycin, and 500 micrograms/ml 
chloramphenicol). These were incubated with shaking at 37° C and the 
number of colony forming units (CFU's) /ml counted. 
WEIGLE REACTIVATION AND MUTAGENESIS 
A concentration of 106 phage D3/ml was exposed to ultraviolet 
radiation at 30 Joules/meter2. A growing culture of bacteria in early 
log phase was treated with antibiotic. At various times 0.2 ml samples 
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of bacteria were removed and exposed to UV-treated phage. After 7 
minutes at room temperature, A top agar was added and the mixture plated 
out on Luria agar plates. After incubating at 37° C overnight, the 
number of plaque forming units were counted to determine Weigle 
reactivation. Also, to determine mutagenesis, the number of D3 wild 
type plaques (cloudy phenotype) which reverted to the D3 mutant plaques 
(clear phenotype) was counted. 
PLASMID MAINTENANCE 
PA0303 and RMB were made competent by MgCl 2 treatment ( 47) and 
transformed with plasmid pME292 which carries resistance to 
carbenicillin. A concentration of 106 plasmid-containing cells/ml were 
exposed to varying concentrations of norfloxacin, nalidixic acid, or 
novobiocin up to the MBC and incubated with shaking at 37° C. After 23 
hours, bacteria were diluted and plated on Luria agar plates. After 
incubating at 37° C overnight, the plates were replica plated onto Luria 
agar plates containing 500 micrograms/ml of carbenicillin. After 
incubation at 37° C, the number of carbenicillin-resistant colonies was 
counted to determine how many still contained the plasmid. 
PURIFICATION OF DNA GYRASE 
Three Luria agar plat~s (40 cm by 24 cm each) were inoculated with 
P. aeruginosa strain PA0303 or ~· coli strand H560 and incubated 
overnight at 37° C. Cells were harvested (wet weight 25 grams) and 
suspended in 100 ml of 0.85% NaCl, incubated with shaking for 10 minutes 
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and centrifuged at 10,000 xg for ten minutes. The pellet was 
resuspended at a concentration of 0.5 g/ml of a 10% sucrose solution 
prepared in 50 mM Tris-HCl (pH 8.0). The suspension was frozen in a dry 
ice-ethanol bath and thawed in a 25° C water bath. The volume was 
measured and 0.1 ml of a solution of lysozyme (2 mg/ml) was added for 
each ml. The mixture was allowed to incubate at o° C for 60 minutes. 
All subsequent reactions were carried out at 4° C. The solution was 
centrifuged for 30 minutes at 35,000 xg. The supernatant was decanted 
(Fraction I) (56). 
The magnesium acetate concentration of this crude extract was 
adjusted to 5 mM and the extract was centrifuged for 4 hours at 30,000 
rpm in a Beckman Ti50 rotor. The supernatant (Fraction II) was loaded 
onto a novobiocin-Sepharous (75) column and washed with buffer A (0.2 M 
KCl, 5 mM dithiothreitol, and 10% glycerol) until the OD280 of the 
eluant reached a minimum. DNA gyrase was eluted from the column with 5 
I 
M urea in buffer A. One ml fractions were collected and dialyzed 
against buffer B (50 mM Tris-HCl, pH 7.5, 1 mM EDTA, and 10% glycerol) 
for 4 hours. The fractions were then dialyzed for an additional 20 
hours against buffer B in the presence of 5 mM dithiothreitol. Each 
fraction was tested for supercoil i ng activity and the active fractions 
pooled. 
PREPARATION OF RELAXED DNA 
Col El DNA was isolated from E. coli strain JC 411 by growing a one 
- -
liter culture in Luria broth to 40 Klett units and amplifying the 
plasmid by adding 200 micrograms/ml of chloramphenicol and incubating in 
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a 37° C water bath with shaking overnight. The cells were then 
harvested at 10,000 xg for 10 minutes, resuspended in saline and 
incubated in a 37° C water bath with shaking for 15 minutes in order to 
deplete the pools of ATP in the cells. The cells were then harvested 
again at 10,000 xg for 10 minutes and resuspended in 33 ml of cold 25% 
sucrose in 50 mM Tris-HCl (pH 8.0) and 6.6 mls of solution containing 2 
mg/ml of lysozyme in 0.25 M Tris-HCl (pH 8.0) was added. After the 
mixture was swirled gently for 5 minutes in a o° C ice bath, 14 ml of 
cold .25 M ethylenediaminetetraacetic acid (EDTA, pH 8.0) was added. 
After mixing at o° C for another 5 minutes, 40 ml of cold two percent 
Sarkosyl in 0.05 M Tris-HCl (pH 8.0) and 0.0625 M EDTA was added. Five 
molar NaCl was added to a final concentration of one molar after another 
five minutes of mixing at o° C. Mixing was then continued at 4° C for 
four hours to overnight. The supernatant was collected after 
centrifugation at 17,000 xg for 30 minutes and DNA was precipitated at 
20° C overnight after adding potassium acetate to a final concentration 
of 0.3 Mand two volumes of 95% ethanol. 
DNA was collected by centrifuging at 12 ,000 xg at o° C for 30 
minutes, discarding the supernatant and drying the pellet. The pellet 
was dissolved in 16 mls of 10 mM Tris-HCl (pH 8.0) and 1 mM EDTA (TE) 
after which 17 .6 grams of cesium chloride and 1.6 mls of 5 ml/ml 
ethidium bromide was added. This mixture, which was kept in the dark 
from this point on in order to avoid nicking of the DNA, was centrifuged 
in a VTI65 rotor at 40.000 xg for 16 hours in a Beckman L5-50 
ultracentrifuge. Under ultraviolet (UV) light, the plasmid band could 
be visualized below the chromosomal band. The plasmid band was isolated 
by inserting a 38.1 mm hypodermic needle just under the band and one at 
30 
the top of the tube. The liquid which flowed out of the tube was 
collected until the band almost disappeared and the chromosomal band was 
nearing the needle. Ethidium bromide was extracted three times with 
isopropanol saturated in a solution of cesium chloride. Potassium 
acetate was added to a concentration of 0.3 M and then four volumes of 
ethanol was added. After keeping at -20° C overnight, DNA was collected 
by centrifuging at 12,000 xg for 15 minutes at o° C, discarding the 
supernatant, drying the pellet and resuspending in TE. The DNA was 
examined and the concentration determined by electrophoresis of 
differing amounts of the DNA on a 0.8% agarous gel gel at 50 volts for 
17 hours with appropriate size and concentration controls. The DNA was 
visualized by staining the gel in 1 mg/ml ethidium bromide and placing 
on a UV light box. 
Supercoiled phage ~X174 (Amersham) or Col El DNA was relaxed with 
topoisomerase I (Amersham). Twenty-five micrograms of DNA and 1.7 units 
of topoisomerase I were incubated at 37° C overnight in a 25 microliter 
volume containing 10 mM Tris-HCl (pH 7.8), 100 mM NaCl, 1 mM EDTA, and 
0.1 mg/ml of bovine serum albumin (BSA). Topoisomerase was inactivated 
by incubating at 70° C for 10 minutes and extracted with chloroform and 
isopropanol at a ratio of 24:1. The product was examined by 
electrophoresis as described above. 
Amersham observed no nuclease activity in the topoisomerase I after 
incubation of 1 microgram of pBR type 1 DNA with 40 units of enzyme for 
30 minutes at 370 C in th~ relaxation buffer described above containing 
1-10 mM MgC1 2• 
Relaxed DNA was also prepared with a nicking-closing extract which 
was prepared from chicken red blood cells as described by Comerini-Otero 
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and Felsenfeld (8). Red blood cells were harvested from whole chicken 
blood by centrifuging at 10,000 xg for 10 minutes. The pellet was 
washed four times with phosphate buffered saline (PBS buffer) by 
centrifugation and resuspension. The cells were then resuspended in 
0.25 M sucrose, 10 mM Tris-HCl (pH 8.0), and 1 mM magnesium acetate and 
washed twice. The cells were washed five times in the same sucrose 
solution and 0.5% (v/v) Triton X-100. The resulting nuclei were then 
washed an additional three times in the absence of Triton. The nuclei 
were swollen by washing them in 10 mM Tris-HCl (pH 8.0), 0.5 mM EDTA. 
In all cases, a Dounce homogenizer (loose pestle) was used for 
resuspension. The nuclei, swollen to about five to ten times their 
original volume, were then mixed with an equal volume of 300 mM 
phosphate buffer (pH 7.5), homogenized with a Dounce homogenizer, and 
centrifuged at 25,000 xg for 15 minutes. The supernatant, which is the 
nicking-closing extract, was monitored for relaxing activity by 
measuring the conversion of supercoiled Col El DNA to the relaxed 
closed-circular form as demonstrated by agarose gel electrophoresis 
(described above). 
The nicking-closing extract was used to prepare relaxed DNA 
substrate in a 50 microliter reaction volume which contained 42 
microliters of nicking-closing extract and 30 micrograms of supercoiled 
Col El DNA or ~Xl74 DNA in 100 mM NaCl, 10 mM Tris-HCl (pH 7.8), 0.25 mM 
EDTA, and 2.5% (v/v) glycerol. The reaction was carried out at 37° C 
for 30 minutes. Enzyme was inactivated by heating at 70° C for 10 
minutes followed by extraction in chloroform:isopropanol at a ratio of 
24:1. The product was examined by agarose gel electrophoresis as 
described above. 
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SUPERCOILING REACTION 
I determined the units of activity of my preparations of DNA gyrase 
as the amount of enzyme required to completely supercoil 0.5 micrograms 
of relaxed DNA at 37° C in 30 minutes in a 25 microliter reaction volume 
containing 50 mM Tris-HCl (pH 7.6), 20 mM KCl, 10 mM MgC1 2, 2 mM 
dithiothreitol, 1.5 mM ATP, 5 mM spermidine-Cl 3, and 50 micrograms/ml 
BSA. If the units were determined using relaxed Col El DNA, then this 
same DNA was used for all subsequent experiments. The same holds true 
for when relaxed ~X174 DNA was used. 
Three other buffers were also used in order to perfect the 
supercoiling conditions, however, they were not used in any of the final 
experiments. The other buffers were: buffer 1 (35 mM Tris-HCl (pH 
7.5), 6 mM MgC1 2, 1.5 mM DTT, 1.5 mM spermidine-HCl, 1.5 mM ATP, and 50 
micrograms/ml of BSA), buffer 2 (35 mM Tris-HCl (pH 7.5), 1.6 mM MgC1 2, 
19 mM KP04 (pH 7.5), 5 mM spermidine-HCl, 1.4 mM ATP, 90 micrograms/ml 
~· coli tRNA, and 3.6 mg/ml BSA), and buffer 3 (35 mM Tris-HCl (pH 7.5), 
20 mM MgCl 2, 20 mM KCl, 0.1 mM EDTA, 10 mM 2-mercaptoethanol, 2 mM 
spermidine-HCl, 1 mM ATP, 40 micrograms/ml BSA, and 10% (w/v) glycerol). 
To stop the reaction, a mixture of 20% Ficoll and 400 micrograms/ml 
of bromopheno l blue was added. The total volume of the samples was 
loaded onto a 0.8% agarous gel and electrophoresed at 50 volts for at 
least 14 hours in TBE (89 mM Tris base, 89 mM boric acid, 2.5 mM EDTA). 
The gels were stained with ethidium bromide (0.5 micrograms/ml) for 15 
! 
minutes and destained in water for 15 minutes before being photographed 
under ultraviolet light. DNA's supercoiled to different extents 
migrated as individual bands with the most greatly supercoiled DNA 
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migrating farthest (lowest band), the completely relaxed DNA migrating 
the least (highest band), and with the linear DNA migrating as a band in 
between the completely relaxed and completely supercoiled DNA. 
RELAXATION REACTION 
One unit of the DNA gyrase preparation was incubated with 0.5 
micrograms of supercoiled ~X174 DNA at 37° C for 2 hours in a 25 
microliter volume containing 35 mM Tris-HCl (pH 7.5), 6 mM MgC1 2, 18 mM 
potassium phosphate, 1.8 nt>1 spermidine-Cl 3, 9 micrograms/ml ~· coli 
tRNA, 0.36 mg/ml BSA, and 5 mM dithiothreitol. The reaction was 
stopped, electrophoresed, and photographed the same as the supercoiled 
reaction. 
The velocity of the relaxation reaction in the presence and absence 
of drug was measured by taking densitometric tracings of negatives of 
gels. As the DNA is relaxed, a ladder of bands between the competely 
supercoiled DNA and completely relaxed DNA bands is observed on the gel. 
As the A subunit decreases the superhelical density by two, the DNA 
molecule will migrate one band up. Each band of DNA was assigned an 
even number depending on where it migrated on the gel. The fastest 
migrating band was assigned zero and the bands above this were given 
even numbers from two up. The to ta 1 decrease in superhe 1ica1 density 
was determined by multiplying the percentage of DNA in each band as 
determined by densitometriF tracings of the negatives of pictures of the 
gels by its assigned number and adding up the products. 
The velocity was derived by plotting the total decrease in 
superhelical density against the time that the reaction was allowed to 
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continue. The slope of the line is equal to the velocity. Linear 
regression was performed on all the data using a Texas Instruments Tl55 
calculator in order to determine the slope of the line. Table 4 shows 
one example of the data used to calculate the velocity for various 
substrate concentrations. Since each experiment did not always result 
in the same number of topoisomer bands, the velocities in the presence 
of different antibiotics cannot be directly compared and the maximal 
velocity determined from these velocity units would be arbitrary. 
The Michaelis constant (Km) of the relaxation reaction was derived 
by a Hanes plot (27), the equation of which is: 
s/v = ~/V + s/V 1. 
where s is the substrate (supercoiled DNA) concentration, v is the 
velocity, and V is the maximal velocity. This shows that a plot of s/v 
against s should be a straight line with slope 1/v and X-intercept -Km. 
The Hanes plot is preferred over the other straight line plots because 
multiplying 1/v by s lessens the large errors that result from taking 
the reciprocal of small v values that have even slight errors in them. 
The inhibition constants (Ki's) of the different pyridonecarboxylic 
acid derivatives were derived by a Dixon plot (12), the equation for 
which is: 
1 - Km ts + CKm/Kj + s/K·'li 
-v- Vs Vs ' 
where i is the inhibitor (pyridonecarboxylic acid) concentration. This 
shows that a plot of 1/v against i at a constant value of s is a 
straight line. When two or more such lines are drawn for two or more 
different s values, the point of intersection along the y axis is equal 
to -Ki. 
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Table 4. Calculation of the Velocity of the Relaxation Reaction. 
Substrate 
Concen~ration (x 10-
mMoles/ml) 
0.85 
1. 7 
3.4 
6.9 
Time 
(min) 
30 
60 
12{) 
30 
60 
120 
60 
120 
180 
30 
60 
" ' 
Decrease in Slope Correlation 
Superhel ical Coefficient 
Density 
62.34 0 .122095 0.944 
69.63 
73.99 
75.54 0.1347619 0.984 
77 .49 
87.25 
76.12 0.1531917 0.980 
81.94 
94.40 
68.63 0.231 1.0 
75.56 
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An exactly similar derivation to the Dixon plot by Cornish-Bowden 
(9) shows that by plotting s/v against i at several s values, a set of 
straight lines that intersect at -K. is again obtained. However, in 
1 
this case, if the lines are parallel the inhibition is competitive. 
CLEAVAGE REACTION 
One unit of the DNA gyrase preparation was incubated with ~X174 DNA 
under the same reaction conditions which were used to determine the 
units of supercoiling activity except that one mg/ml of 
pyridonecarboxylic acid and, in some cases, 1.5 mM ATP or 1.5 mM 
adenylyl-imidodiphosphate (AppNp) was added. After 30 minutes, 11 mM 
EDTA, 2 mg/ml SDS, and in one case 90 micrograms/ml of proteinase K was 
added. The incubation was continued for 60 minutes. The reaction was 
electrophoresed and photographed the same as the supercoiling reaction. 
CATENATION REACTION 
This reaction was not specifically tested for, but was observed 
when the supercoiling reaction products were examined. On the gels that 
contained the supercoiling reactions products, bands that migrated much 
higher than the relaxed DNA band appeared. In some cases, the reaction 
was extracted with a 24:1 mixture of chloroform and isopropanol before 
loading, the gel. 
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ATPase REACTION 
ATPase activity was measured in the supercoiling reaction mixture 
(described in the Supercoiling Reaction section) after the 30 minute 
incubation by measuring the release of inorganic phosphate as described 
by Lanzetta et ~· (46). Two control reactions carried out in the 
absence of DNA gyrase or ATP were also measured for release of inorganic 
phosphate. 
The following stock solutions were prepared with distilled water in 
glassware that was well rinsed in order to remove any detergents that 
may have been left over from the dishwashing process: 0.045% malachite 
green hydrochloride (MG}, 4.2% ammonium molybdate in 4 N HCl (AM), 34% 
sodium citrate-2H2o (w/v), and 10 mM KH2Po4 (salt was dried several 
hours at 100° C}; appropriate dilutions were made from this stock and 
used for standards. The color reagent was prepared from the above 
solutions as follows: a 3:1 mixture of MG and AM solutions was mixed at 
least 20 minutes and then passed through Whatman No. 5 filter paper 
(MG/AM), and 100 microliters of Sterox (purchased from Coleman 
Instruments) was added to 5 ml of MG/AM solution (MG/AM/St). To 25 
microliters of sample or standard, 400 microliters of the MG/AM/St 
solution was added mixed. After one minute, 100 microliters of the 
citrate solution was added and mixed. The 00660 of this solution was 
read after allowing it to sit at room temperature for 2 hours. A 
standard calibration curv~. was prepared from the standards previously 
described every time the experiment was performed. The 00660 of the 
supercoiling reactions was compared to this standard curve in order to 
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determine the amount of inorganic phosphate released (the amount of ATP 
hydrolyzed) as compared to the controls. 
EFFECTS OF ANTIBIOTICS 
The reactions of DNA gyrase were carried out as described above in 
the presence of norfloxacin, nalidixic acid, oxolinic acid, or 
novobiocin at concentrations ranging from the MIC to one mg/ml. 
RESULTS 
POTENCY OF PYRIDONECARBOXYLIC ACID DERIVATIVES ON P. AERUGINOSA 
The potency of norfloxacin and nalidixic acid as bacteriostatic and 
bactericidal agents for the strains to be used in this study was 
determined by measuring the MIC and MBC of both drugs (Table 5). These 
concentrations were consistent with those determined for other strains 
of f. aeruginosa (30). Norfloxacin was several hundred to a thousand 
fold more potent than nalidixic acid for all strains tested. Strains 
deficient in recombination (Rec-) were studied because Rec- E. coli 
strains were found to be unable to recover from inhibition of DNA 
synthesis (19). Our Rec- strain RMB was slightly more resistant than 
its parent, strain PA0303, to both norfloxacin and nalidixic acid. 
Another Rec- strain, PA02002 was slightly less resistant to nalidixic 
acid and exhibited the same level of tolerance to norfloxacin. Since 
the exact reasons for the Rec- phenotypes of these strains is unknown, 
speculation as to why the mutations cause differences in 
pyridonecarboxylic acid resistance is left for a later date. However, 
it does appear that recombination is somehow involved in drug 
resistance. 
Spontaneous mutants, of PA0303 resistant to norfloxacin (RM166, 
RM167, and RM169) were isolated as described in Materials and Methods 
and found to also be resistant to nalidixic acid. RM4000, a spontaneous 
mutant of RMB resistant to nalidixic acid which happened to be available 
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Table 5. The MIC's and MBC's for Norfloxacin and Nalidixic Acid 
in f. aeruginosa Strains 
Strain Nalidixic Acid Norfloxacin 
MIC MBC MIC MBC 
(micrograms/ml) (micrograms/ml) 
PA0303 350 2000a 0.4 16.0 
RM166 (Norr) 2000 3000b 6 20.0 
RM167 (Norr) 2700 3000b 9 20.0 
RM168 (Norr) 3000 3000b 8 20.0 
RM169 (Norr) 2500 3000b 6 15.0 
RMB (Rec-) 700 2000a 1.6 16.0 
RM4000 (Nalr) 3000 3000b 6a 20a 
PA02001 175 700a 1.6 2.5a 
PA02002 (Rec-) 44 700a 1.6 2.5a 
~This is an approximate value. 
This is a minimum value due to the insolubility of nalidixic acid at 
concentrations above 3000 micrograms/ml. 
" ' 
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in our lab, was found to also be resistant to norfloxacin. This 
indicates that the two drugs act similarly in that they have the same 
mechanism of transport into the cells, they have the same targets of 
action, or both. 
The optical density of a culture of cells is a measure of the 
number of cells in that culture. The optical density of a growing 
culture of E· aeruginosa cells increases exponentially over time (Figure 
4). When a culture in exponential (log) growth phase was treated with 
norfloxacin at a concentration equal to the MIC (0.4 micrograms/ml) or 
four times the MIC (1.6 micrograms/ml), the rate of growth decreased for 
about 100 minutes after which there was no more growth. When a 
concentration equal to the M8C (16 micrograms/ml} was used, there was an 
immediate inhibition of growth. A culture in late log phase, however, 
exhibited no significant decrease in the growth rate when treated with 
the M8C of norfloxacin (Figure 5). 
When PA0303 was exposed to nalidixic acid or norfloxacin at a 
concentration equal to the M8C for these drugs (16 micrograms/ml and 
2800 micrograms/ml}, the number of colony-forming units (CFU's) 
recovered was drastically reduced (Figures 6A and 7A). When 
chloramphenicol or rifamycin was also present in the culture medium, it 
eliminated the bactericidal effects of norfloxacin and nal idixic acid. 
Any reduction in CFU's/ml could be attributed to the bacteriostatic 
effect of chloramphenicol or rifamycin alone. When these experiments 
(Figures 68 and 78), were repeated with the~, Rec strain RMB 
chloramphenicol did not alleviate the bactericidal effects of 
norfloxacin or nalidixic acid. 
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Figure 4. Inhibition of Mid-Log Phase Growth by Norfloxacin. 
The growth of a culture o.f PA0303 was followed by measuring the Klett 
(0066) at various times. At 150 minutes, the culture was divided into 
four portions. Each portion was treated with buffer containing norflox-
acin at the MBC (Q), four times the MIC (0), the MIC (*),or buffer 
containing no drug(~). 
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Figure 5. The Effect of Norfloxacin on Late-Log Phase Growth. 
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The growth of a culture of PA0303 was fo 11 owed by measuring the Klett 
(00660) at various times. At 200 minutes, the culture was divided. 
Half was treated with the.MSC of norfloxacin (O) and half was treated 
with buffer containing no drug(~). 
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Time (hr) 
Figure 6. The Bactericidal Effect of Pyridonecarboxylic Acid and 
Chloramphenicol. 
Logarithmically grow.ing cultures of PA0303 ()\)\and RMS (B) were divi.d~d. 
Portions were treated with norfloxacin (~J, nalidixic acid (~), 
chloramphenicol (.), nor:floxacin and chloramphenicol ( }, nalidixic 
acid and chloramphehicol .(.), or buffer without added drug (e) as 
described in the text. At various times, samples were taken and the 
CFU/ml of the culture determined. 
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Figure 7. The Bactericidal Effect of Pyridonecarboxylic Acids and 
Rifamycin. 
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Logarithmically growing cultures of PA0303 (A) and RMB (B) were divided. 
Portions were treated with norfloxacin (~), nalidixic acid (()}, 
rifamycin (0), rifamycin· and norfloxacin (-*), rifamycin and nalidixic 
acid (()},or buffer without added drug(~) as described in the Methods 
section. At various times, samples were taken and the CFU/ml of the 
culture determined. 
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FI LAMENTATION 
Filamentation was not seen when PA0303 was treated with nalidixic 
acid or norfloxacin (Figure BA and C, respectively}. Cell division 
events were observed even after 23 hours of treatment when the number of 
CFU's/ml indicate that the cells are no longer viable (Figures 6 and 7, 
BA and BC). Simultaneous treatment with both chloramphenicol and 
pyridonecarboxyl ic acid did not stop the cell division events from 
taking place (Figure BE). 
Many of the Rec- strain (RMB) cells treated with nal idixic acid 
filamented (Figure BB}, while only very few of the cells treated with 
norfloxacin showed even a slight increase in size (Figure BD). Some of 
the cells treated simultaneously with nalidixic acid and chloramphenicol 
filamented also (Figure BF). In all cases, cell division events were 
observed. 
RATE OF PROTEIN SYNTHESIS 
The rate of protein synthesis in an exponentially growing culture 
of f. aeruginosa increases logarithmically with time (Figure 9). 
Nalidixic acid inhibited protein synthesis about 99 percent, while 
norfloxacin inhibited protein synthesis only about 50 percent. 
~ATE OF DNA SYNTHESIS 
The rate of DNA synthesis in a growing culture of f. aeruginosa 
cells (PA0303) was inhibited by norfloxacin (Figure 10). Increasing the 
Figure 8. 
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Lethal Unbalanced Growth in Pyridonecarboxylic Acid Treated 
Cells. 
The cultures described in Figure 5 were photographed at a magnification 
of xl800 after 24 hours of incubation. Strain PA0303 (A, C, E, and G) 
or RMB (B, D, F, and H) were treated with norfloxacin (C and D}, nali-
dixic acid (A and B), nal idixic acid and chloramphenicol (E and F) or 
buffer containing no drugs (G and H). Arrows point out cells that 
appear to have just completed cell division. 
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Figure 9. Inhibition of Protein Synthesis by Pyridonecarboxylic Acids. 
Logarithmically growing cultures of RMS were divided, and portions were 
treated with four times the MIC of norfloxacin (~.), four times the MIC 
of nalidixic acid(*), or buffer containing no drug (e). At various 
times, samples were taken and the rate of protein synthesis measured as 
described in the text. 
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Figure 10. Inhibition of the Rate of DNA Synthesis as a Function of 
Norfloxacin Concentration. 
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Logarithmically growing cultures of strain PA0303 ( O), RMB (0), or 
RM168 (A) were divided and exposed to various concentrations of nor-
floxacin. The rate of DNA synthesis was measured after four minutes of 
exposure as described in the text. 
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concentration of norfloxacin resulted in an increase in the amount of 
inhibition up to a plateau that occurred around the MBC (16 
micrograms/ml). RMB (the Rec- mutant) and RM16B (the spontaneous mutant 
resistant to norfloxacin) were inhibited to a lesser extent than their 
parent PA0303 (Rec+, Nors). In order to keep these experiments 
consistent with similar experiments performed on E. coli (20), a drug 
concentration of four times the MIC was used. 
The rate of DNA syn thesis of a culture of P. aerugi nos a in log 
phase increased exponentially over time (Figure 11). Treatment of 
PA0303 (Rec+) with either norfloxacin or nalidixic acid (Figure llA and 
12, respectively) at a concentration of four times the MIC caused an 
immediate inhibition of DNA synthesis followed by recovery synthesis 
that was also exponential and that occurred within 5 minutes of drug 
treatment. No recovery synthesis was observed at concentrations equal 
to the MBC of norfloxacin (Figure llA). Inhibition of protein synthesis 
simultaneously with norfloxacin treatment did not allow recovery 
synthesis (Figure 13A). 
When RMB was treated with nalidixic acid at a concentration of four 
times the MIC (Figure 128), recovery synthesis occurred but could not be 
sustained, whereas it could be sustained if norfloxacin was used (Figure 
llB). Concentrations as high as the MBC for norfloxacin allowed 
recovery synthesis that could be sustained (Figure 118). This 
difference observed between nalidixic acid and norfloxacin in the Rec-
mutant may be because na
1
Jidixic acid inhibits protein synthesis 99%, 
while norfloxacin inhibits protein synthesis only 50%. If protein 
synthesis was inhibited simultaneously with norfloxacin treatment 
(Figure 13A), the recovery synthesis could no longer be sustained in the 
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Figure 11. The Effects of Norfloxacin on the Rate of DNA Synthesis in 
PA0303 and RMB Cultures. 
Logarithmically growing cultures of PA0303 (A), RMB (B), and RM16B (C) 
were divided and portions ,were exposed to four times the MIC of norfl ox-
acin (0), the MBC or norfloxacin (0), or buffer containing no drug 
( •.). At various times, samples were taken and the rate of DNA synthe-
sis measured as described in the text. 
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Figure 12. The Effects of Nalidixic Acid on the Rate of DNA Synthesis 
in PA0303 and RMB Cultures. 
Logarithmically growing cultures of PA0303 (A) and RMB (B) were divided, 
half was treated with four times the MIC of nalidixic acid (0), and 
half was treated with buffer containing no drug (~). At various times, 
samples were taken and the rate of DNA synthesis measured as·described 
in the text. 
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Figure 13. The Effects of Simultaneous Treatment with Norfloxacin and 
Chloramphenicol on the Rate of DNA Synthesis in PA0303 and 
RMB Cultures. 
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Logarithmically growing cuJtures of PA0303 (A) and RMB (B) were divided 
and portions were exposed to chloramphenicol ([]), chloramphenicol and 
norfloxacin (()), or buffer without added drugs (~). At various times 
after introduction of the drug(s), samples were taken, and the rate of 
DNA synthesis measured as described in the text. 
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Rec- mutant. Inhibition of protein synthesis simultaneously with 
nalidixic acid treatment had no effect on the recovery synthesis in 
either the Rec+ or Rec- strains. 
The rate of DNA synthesis of another Rec- mutant (PA02002) and its 
parent (PA02001) were measured (Figure 14). These strains have a very 
long generation time of 75 minutes as compared to the generation time of 
30 minutes for strain PA0303, accordingly, their rate of DNA synthesis 
is much slower than strain PA0303. Norfloxacin or nalidixic acid 
treatment caused an immediate inhibition of DNA synthesis followed by 
recovery synthesis in the parent (Figure 14A and C) or by a slower rate 
of inhibition in the Rec- mutant (Figure 148 and D). Since the slopes 
of these lines were so small, linear regression was performed on these 
lines to determine if their slopes were indeed positive in the case of 
strain PA02000 and negative in the case of strain PA02001. These slopes 
are given in the figure legend. 
RM168, a spontaneous mutant of PA0303, resistant to norfloxacin, 
was inhibited to a lesser extent than its parent (Figure 10). However, 
its inhibition and recovery of DNA synthesis occurred within the same 
time frame as the wild type's (Figure llC). 
RM4000, a spontaneous mutant of RMB, resistant to nalidixic acid, 
exhibited no recovery synthesis when treated with norfloxacin or 
nalidixic acid (Figures 15A and B, respectively). 
INDUCTION OF DNA REPAIR PATHWAYS 
Inducible DNA repair systems in a bacterium can be studied by 
treating cells with an inducing agent such as ultraviolet radiation or 
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Figure 14. The Effects of Norfloxacin and Nalidixic Acid on the Rate of 
DNA Synthesis in PA02001 and PA02002 Cultures. 
Logarithmically growing cultures of PA02001 (A and C) and PA02002 (B and 
D) were divided, half wa$ treated with norfloxacin (A and B) or nali-
dixic acid (C and D) at a concentration of four times the MIC (()) and 
half was treated with buffer containing no added drug (e). At various 
times, samples were taken and the rate of DNA syn thesis measured as 
described in the text. The slopes of the lower lines are +0.376 for A, 
-0.16 for B, +0.111 for C, and -0.029 for D. 
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Figure 15. The Effects of Norfloxacin and Nalidixic Acid on the Rate of DNA Synthesis in Strain 
RM4000. 
Logarithmically growing cultures of RM4000 were divided, half was treated with norfloxacin (A) or 
nalidixic acid (B) at a concentration of four times the MIC (O), and half was treated with buffer 
containing no added drug ( •). At various times, samples were taken and the rate of DNA synthesis 
measured as described in the text. 
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nalidixic acid and subsequently infecting the treated cells with 
UV-damaged phage DNA. The cells are plated out and the number of plaque 
forming units (PFU's) counted. If a DNA repair system has been induced 
by the agent, then the number of PFU's in the treated culture will be 
exponentially greater than the number of PFU's in the control culture. 
This phenomenon, termed Weigle reactivation, is observed in E. coli 
cells treated with nalidixic acid (69). 
Mutagenesis can be measured during the same experiment. The 
Pseudomonas phage D3 has a high frequency of mutation to the clear 
plaque phenotype as opposed to the wild type cloudy plaque. If a DNA 
damaging treatment is inducing an error-prone repair system, then the 
percentage of clear plaques in the treated culture will be greater than 
the percentage of clear plaques in the control culture. 
Neither Weigle reactivation (Figure 16) nor mutagenesis (Table 6) 
was observed when PA0303 (Rec+) or RMB (Rec-) cells were treated with 
norfloxacin or nalidixic acid. This is not surprising, since treatment 
with ultraviolet light does not induce these pathways in the Rec+ or 
Rec- strains of P. aeruginosa (66). 
PLASMID MAINTENANCE 
Treatment of ~· coli strains containing plasmid pBR322 or plasmid 
pMGllO with coumermycin Al, an inhibitor of the DNA gyrase B subunit, 
results in loss of thes~, plasmids from the cells (B5). The plasmid 
pME292 was transformed into PA0303 and RMB made competent by MgCl 2 
treatment (53). Treatment with varying concentrations of norfloxacin, 
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Figure 16. The Absence of Weigle Reactivation in Strains PA0303 and RMB. . 
At time zero, a culture of PA0303 (A and C) and RMB (B and D) was 
treated with either norfloxacin (A and B) or nalidixic acid (C and D) at 
a concentration of four times the MIC. At various times, samples were 
taken, and infected with UV-irradiated (30 J/m2) phage 03. The titer of 
phage (PFU/ml) relative to the titer at time zero was determined. 
Drug 
Table 6. Frequency of Mutagenesis in the Presence of 
Norfloxacin or Nalidixic Acid. 
Time of Exposure Mutation Fr~quency 
(min) (mutants/10 PFU) 
Norfloxacin 0 10 
5 11 
30 11 
50 8 
Nalidixic 0 17 
5 9 
30 11 
50 6 
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nalidixic acid, or novobiocin up to the MBC's did not cause any loss of 
plasmid from either strain (Table 7). 
PSEUDOMONAS AERUGINOSA DNA GYRASE 
DNA gyrase was isolated from strain PA0303 by affinity 
chromatography (Table 8) on a novobiocin-Sepharous column {75) and found 
to consist of two subunits whose molecular weights were determined to be 
92,000 ~ 3,000 and 108,000 ~ 3,000 by SOS polyacrylamide gel 
electrophoresis. Depending on the preparation, either two or four bands 
were observed on the SOS gel of the final purified fraction. The 92,000 
and 108,000 bands, which are presumably the two subunits of DNA gyrase, 
appeared consistently. Two other less intense bands of molecular 
weights 40,000 and 50,000 were sometimes observed. Unfortunately, with 
the equipment available and with my lack of expertise in the area of 
photography, I was unable to obtain a photograph that could distinguish 
these bands very well (Figure 17). 
The two smaller, less intense bands may consist of proteins which 
bind to novobiocin since the preparation eluted off of a well washed 
novobiocin-Sepharous affinity column. Staudenbauer and Orr (75) also 
observed two smaller additional proteins other than the DNA gyrase 
subunits eluting off of the novobiocin-Sepharous affinity column loaded 
with an E. coli extract. One of these additional proteins, which has a 
molecular weight of 85,00.0, has an unknown function. They speculate 
,. 
that the other protein of molecular weight 40,000 may be generated from 
the same proteolytic cleavage event that generates the v subunit of 
molecular weight 50,000. The two smaller, less intense bands which I 
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Table 7. Plasmid Maintenance 
Drug Concentration Plasmid Maintenance 
(micrograms/ml) {percent) 
Norfloxacin 0 99.9 
0.2 99.9 
0.4 99.9 
1.6 99.9 
Nalidixic Acid 0 99.9 
350 99.9 
700 99.9 
Novobiocin 0 99.9 
1 99.9 
The data is exactly the same for strains PA0303 and RMB. 
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Table 8. Purification of P. aeruginosa DNA Gyrase. 
Total Total Total Specific 
Volume Protein Enzyme Activity 
Fraction (ml) (mg) Activity units/mg 
I 22.5 4.896 * * 
II 20 4.096 * * 
II I 5 0.29 2000 34,483 
*No enzyme activity could be determined in these fractions. 
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Figure 17. SOS Polyacrylamide Gel of Purified f. aeruginosa DNA Gyrase. 
Purified P. aeruginosa DNA gyrase (lane 1) and SDS-PAGE high molecular 
weight standards llane 2) were electrophoresed in 10% SOS polyacrylamide 
tube gels. 
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observed, also might consist of proteolytic products of the B subunit 
and maybe even the A subunit. The proteolysis may have occurred before, 
during or after the purification procedure. The B subunit may also 
autoproteolyze, a phenomenon which is also observed for the 1· coli lexA 
protein (46). This autoproteolysis is suspected of my purified f. 
aerugi nos a DNA gyrase because of the disappearance of the supercoil i ng 
activity with time or freezing, as will be described in the next 
section. 
,SUPERCOILING OF RELAXED CLOSED CIRCULAR DNA 
The supercoi 1 i ng of re 1 axed DNA by my purified f. aerugi nos a DNA 
gyrase exhibited many irregularities. First of all, there were problems 
with the substrate (relaxed Col El or ~Xl74 DNA). After many 
unsuccessful attempts at increasing the superhe 1ica1 density of the 
substrate with my purified f. aeruginosa DNA gyrase, I sent a sample of 
my substrate to Dr. Martin Gellert. His purified 1· coli DNA gyrase was 
also unable to supercoil my substrate. In order to relax supercoiled 
DNA for substrate, I had been using a chicken nicking-closing extract 
which was available in our lab and was about three or four years old. I 
therefore prepared fresh nicking-closing extract, which I used to relax 
supercoiled DNA. This also led to relaxed DNA that was not 
supercoilable (Figure 18). I then attempted to improve the reaction 
conditions by carrying ou~ the reaction in different buffers (described 
in the Methods section), none of which improved the results. E. co 1 i 
DNA purified using the exact same procedure as used for f. aeruginosa 
DNA gyrase was also unable to supercoil the substrate prepared with 
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Figure 18. Lack of Supercoiling Activity off. aeru~inosa and~· coli 
DNA Gyrase on Nicking-Closing Extract-Re axed DNA. 
Col El DNA relaxed with nicking-closing extract was incubated with f. 
aeruginosa DNA gyrase (lanes 9-13) or~· coli DNA gyrase (lanes 2-8) as 
described in the Methods section. Ea~ane contains a different 
fraction collected from the novobiocin-Sepharose column. Lane 1 con-
tains relaxed DNA incubated in the absence of DNA gyrase, and lane 14 
contains supercoiled DNA. 
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fresh nicking-closing extract (Figure 18). Finally, I utilized 
topoisomerase I as a relaxing agent. This resulted in relaxed DNA that 
was supercoilable (Figures 19 and 21). 
I only attained supercoiling on a fresh preparation of DNA gyrase 
that was less than 24 hours off of the column and that had never been 
frozen (Figure 19). After the preparation was one day old or had been 
frozen, I attained cut linear DNA. Figure 19 shows the agarose gel of 
the reaction products obtained when relaxed Col El DNA was used with a 
fresh preparation of DNA gyrase, and Figure 20 shows the reaction 
products from the same preparation that had been frozen. It appears 
that the circular Col El DNA treated with the older preparations 
obtained a double-stranded cut resulting in linear DNA. Figures 21 and 
22 exhibit the reaction products obtained when relaxed 0Xl74 DNA was 
used with a fresh or frozen preparation, respectively. It appears that 
the circular ~Xl74 DNA treated with the older preparation obtained two 
double-stranded cuts resulting in two linear bands which migrate to the 
same location as the linear DNA of the cleavage reaction (see Cleavage 
Reaction section). The double-stranded cleavage may result from 
proteolytic products of the B subunit that are similar to the I· coli v 
subunit. Since the v subunit is a natural protein found in I· coli and 
f. aeruginosa possesses a DNA gyrase very similar to the I· coli enzyme, 
it is not unlikely that f. aeruginosa also possesses a v subunit similar 
to the I· coli v subunit. The loss of the supercoiling activity and the 
gain of cleavage activityrmay be due to the v subunit being more stable 
than the B subunit. 
When I used relaxed Col El DNA, bands of topoisomers that were 
increased in superhelical density occurred, but a completely supercoiled 
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Figure 19. Supercoiling of Topoisomerase I-Relaxed Col El DNA by Fresh £. aeruginosa DNA Gyrase Preparation. 
Col El DNA, which was relaxed with topoisomerase I, was incubated with £. aeruginosa DNA gyrase (lanes 2-9) as described in the Methods 
section. Each lane contains a different fraction collected from the 
novobiocin-Sepharose column. Lane 1 contains relaxed DNA incubated in 
the absence of DNA gyrase~ and lane 10 contains supercoiled DNA. 
34 5 6 7 8 9101112 
Figure 20. Effects of Frozen £. aeruginosa DNA Gyrase Preparation on 
Topoisomerase I-Relaxed Col El DNA. 
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Col El DNA, which was incompletely relaxed with topoisomerase I, was 
incubated with £. aeruginosa DNA gyrase preparations which had been 
stored frozen as described in the Methods section (lanes 2-8 and 10-11). 
Each lane contains a different fraction collected from the novobiocin-
Sepharose affinity column. Lane 1 contains incompletely relaxed DNA 
incubated in the absence of DNA gyrase, lane 9 contains no DNA, and lane 
12 contains supercoiled DNA. 
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Figure 21. Supercoiling of Topoisomerase I-Relaxed 0X174 DNA by Fresh 
Preparations off. aeruginosa DNA Gyrase. 
Topoisomerase I-relaxed 0X174 DNA was incubated with a fresh preparation 
of DNA gyrase as described in the Methods section. Each lane contains a 
different amount of preparation (12 µl in lane 2, 11 µl in lane 3, 10 µl 
in lane 4, 9 µl in lane 5, 8 µl in lane 6, 7 µl in lane 7, 6 µl in lane 
8, 5 µl in lane 9, 4 µl ir:i lane 10, 3 µl in lane 11, 2 µl in lane 12, 
and 1 µl in lane 13 - for a 25 µl total reaction volume). Lane 1 
contains relaxed DNA incubated in the absence of DNA gyrase and lane 14 
contains supercoiled DNA. 
Figure 22. Effect of Frozen ~· aeruginosa DNA Gyrase Preparations on 
Topoisomerase I-Relaxed 0Xl74 DNA. 
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Topoisomerase I-relaxed 0Xl74 DNA was incubated with preparations of DNA 
gyrase which were stored frozen for 24 hrs as described in the Methods 
section. Of the 25 µl reaction volume, DNA gyrase preparation repre-
sented 11 µl in lane 1, 10 µl in lane 2, 9 µl in lane 3, 8 µl in lane 4, 
7 µl in lane 5, 6 µl in lane 6, 5 µl in lane 7, 4 µl in lane 8, 3 µl in 
lane 9, 2 µl in lane 10, 1 µl in lane 11, 1/2 µl in lane 12, 1/10 µl in 
lane 13, and 0 µl in lane 16. Lanes 14 and 15 contain 11 µl of DNA 
gyrase preparation which were stored frozen for a week and longer. Lane 
17 contains supercoiled DNA. 
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product was never observed. When I used ~X174 DNA, completely 
supercoiled DNA appeared but no intermediate topoisomers were ever 
observed (Figure 21). Intermediate topoisomers were observed, however, 
when supercoiled ~X174 DNA was relaxed with new or old DNA gyrase 
preparations (see next section). 
Inhibition of supercoiling by pyridonecarboxylic acids was not 
observed. An unexpected phenomenon did occur with topoisomerase 
I-relaxed Col El DNA (Figure 23); supercoiling was not observed in the 
absence or at low concentrations of pyridonecarboxylic acids, but 
intermediate topoisomer bands appeared in reactions carried out in the 
presence on MBC concentrations of norfl oxaci n ( 16 micrograms/ml) and 
nalidixic acid (2800 micrograms/ml). This phenomenon can be explained 
if the relaxing activity of the topo II' is greater in this preparation 
than the supercoiling activity of DNA gyrase. In the absence of 
pyridonecarboxyl ic acids, the v subunit relaxes DNA more efficiently 
than DNA gyrase supercoils this same DNA, thus preventing the appearance 
of a supercoiled band. At higher pyridonecarboxylic acid 
concentrations, the relaxing activity of topo II' may be inhibited to a 
greater extent than the supercoiling activity of DNA gyrase and 
intermediates between the completely supercoiled DNA (DNA gyrase 
reaction products), and completely relaxed DNA (topo II' reaction 
products) are observed. 
RELAXATION OF SUPERCOILED DNA 
P. aeruginosa DNA gyrase relaxed supercoiled DNA in the absence of 
ATP (Figure 24, lane 2), but not in the presence of ATP (lane 3). In 
1 2 3 4 5 6 7 8 9 10 
Figure 23. Inhibition of the Supercoiling Reaction by Pyridonecar-
boxylic Acids. 
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Topoisomerase I-relaxed Col El DNA was incubated with .a fresh prepara-
tion of DNA gyrase as described in the Methods section (lane 8). 
Norfloxacin was added at a concentration of 0.4 µg/ml in lane 4. 
Nalidixic acid was added at a concentration of 350 µl/ml in lane 5 and 
1400 µl/ml in lane 6. Novobiocin was added to lane 7 at a concentration 
of 10 µl/ml. Lane 9 contains no DNA and lane 10 contains supercoiled 
DNA. 
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Figure 24. The Relaxation of Supercoiled DNA by P. aeruginosa DNA 
Gyrase. -
Supercoiled ~X174 DNA (lane 1, lower band) containing some relaxed DNA 
(upper band) was incubated with f. aeruginosa DNA gyrase in the absence 
of ATP (lane 2), in the presence of AppNp (lane 4), in the absence of 
magnesium (lane 5), in the presence of norfloxacin at concentrations of 
1.6 µl/ml (lane 6), 6.4 µg/ml (lane 7), 16 µg/ml (lane 8), and 100 µg/ml 
(lane 9), in the presence of nalidixic acid at concentrations of 350 
µg/ml (lane 10, and 700 µg/ml (lane 11), and in the presence of 100 
µg/ml of novobiocin. The ladder of bands in between the relaxed and 
supercoiled bands consists of topoisomers differing by two linking 
numbers. Lanes 1-5 contain 0.5 µg of DNA, and lanes 6-12 contain 0.3 µg 
of DNA. 
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the presence of adenylyl-imidodiphosphate (AppNp) nonhydrolyzable analog 
of ATP (lane 4), the relaxation occurred to a lesser extent that in its 
absence. The velocity of the relaxation reaction was measured as 
described in the Methods section. By measuring the velocity over time 
for different substrate (supercoiled ~X174 DNA) concentrations and 
graphing a Hanes plot of the results as described in the Methods section 
(Figure 25), the Km of the relaxation reaction was determined to be 
1.1 +/- 0.5 x 10-9 Molar (3.82 +/- 1.2 x 10-3 g/l). 
The relaxation reaction was inhibited by norfloxacin (Figure 24, 
lanes 6-9), and nalidixic acid (lanes 10 and 11), but not by novobiocin 
(lane 12). Increasing the concentration of norfloxacin or nalidixic 
acid caused an increase in the extent of inhibition (lanes 6-9 and lanes 
10 and 11, respectively). Carrying out the relaxation reaction in the 
presence of increasing concentrations of pyridonecarboxylic acid 
resulted in an increase in the electrophoretic mobility of the ladder of 
topoisomer bands (i.e., smaller extent of relaxation) and an increase in 
the fraction of products located in the completely supercoiled band 
(i.e., less molecules relaxed). Figure 26 demonstrates this phenomenon 
for relaxation on supercoiled ~X174 DNA in the presence of increasing 
concentrations of norfloxacin. The inhibition constants (Ki's) of the 
pyridonecarboxylic acid derivatives on the relaxation reaction were 
determined by carrying out the reaction in increasing concentrations of 
drugs for sets of reactions containing differing concentrations of 
supercoiled ~X174 DNA and calculating the velocities as described in the ; 
Methods section. Dixon plots were drawn from the resulting data as 
described in the Methods section. The Ki for norfloxacin was derived to 
be 2.0 x 10-3 Molar (650 micrograms/ml, Figure 27), 3.7 x 10-3 Molar 
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Figure 25. Hanes Plot of the Relaxation Reaction. 
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18 22 
The velocity (v) of the relaxation reaction was determined at varying 
substrate concentrations (s) as described in the Methods section. s/v 
is plotted against s and the x-intercept is equal to -Km. The three 
different lines represent three different experiments performed on two 
separately isolated prfparations. The average of the three x-intercepts 
is63.82 +/- 1.2 x 10- gl,1 since the molf9Cular weight of fl)X174 is 3.5 x 10 , the Km is equal to f.1 +/- 0.5 x 10- Molar. 
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Figure 26. Increasing Concentrations of Pyridonecarboxylic Acid Result 
in Greater Inhibition of the Relaxation Reaction. 
The relaxation reaction was carried out ·in the presence of norfloxacin 
at concentrations of 1 µg/ml (lane 1), 250 µg/ml (lane 2), 500 µg/ml 
(lane 3), 750 µg/ml (lane 4) and 1000 µg/ml (lane 5). An agarose gel of 
the reaction products is on the right and a densitometric tracing of the 
negative of the picture of this gel is on the left. R is the distance 
migrated by completely relaxed DNA, and S is the distance migrated by 
completely supercoiled DNA. 
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Figure 27. Dixon Plot of the Inhibition of P. aeruginosa DNA Gyrase-
Catalyzed Relaxation by Norfloxacin. 
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The relaxation reaction was carried out in various §Oncentrations of 
norfloxac:igl and substrate concentratiigt1S of 1.7 x 10- mMoles/ml (d}a 
3.4 x 10- mMoles/ml (*), 6.9 x 10- mMoles/ml (O), and 1.8 x 10 
mMoles/ml (~) as described in the Methods section. 
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(975 micrograms/ml) for oxolinic acid (Figure 28), and 10.8 x 10-3 Molar 
(2500 micrograms/ml) for nalidixic acid (Figure 29). 
A Cornish-Bowden plot (9) of the substrate concentration (s) 
divided by the velocity (v) versus the inhibitor concentrations (i) 
plotted at several (s) values will reveal what type of inhibition is 
occurring. If the lines are parallel, the inhibition is competitive. 
If the lines intersect below the x axis, the inhibition is mixed, and if 
the lines intersect above the x axis, the inhibition is uncompetitive. 
Cornish-Bowden plots of the inhibition of relaxation by norfloxacin 
(Figure 30), nalidixic acid (Figure 31), and oxolinic acid (Figure 32) 
resulted in lines that appear to be parallel except for the lines at low 
substrate concentrations. Analysis of covariance tests of the slopes of 
all of the lines for each derivative indicate that the lines are not 
parallel (Tables 9, 10, and 11). The type of inhibition exerted by 
these drugs may be different at low and high substrate concentrations, 
however. An analysis of covariance tests on a 11 of the 1 i nes for 
norfloxacin excluding the line of lowest substrate concentration 
indicates that the lines are significantly parallel (p < .01; Table 12). 
This. indicates that the type of inhibition is competitive at higher 
substrate concentrations and uncompetitive at lower substrate 
concentrations. 
Increasing concentrations up to 1 mg/ml of novobiocin did not 
inhibit the relaxation reaction (Figure 22). This is expected, since 
novobiocin is an inhibitpr of the B subunit of DNA gyrase and the 
relaxation reaction is a property of the A subunit. 
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Figure 28. Dixon Plot of the Inhibition of P. aeruginosa DNA Gyrase-
. Catalyzed Relaxation by Oxolinic-Acid. 
The relaxation reaction was carried out in various ~ncentrations of 
oxolinic ~id and substrate concentrat~ons of 1.7 x 10- mMoles/ml (1t18 3.4 x 10- mMoles/ml (0), 6.9 x 10- ntloles/ml ( 0), and 1.8 x 10 
mMoles/ml (~) as described in the Methods section. 
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Figure 29. Dixon Plot of the Inhibition of ~· aeruginosa DNA Gyrase-
Catalyzed Relaxation by Nalidixic Acid. 
80 
The relaxation reaction was carried out in various concen~rations of 
nalidixic acid ~d substrate concentrations of lg7 x 10- ti1Md11:!s/ml 
(*), 3.4 x 10- mMoles/ml (0), and 6.9 x 10- mMoles/ml (e) as 
described in the Methods section. 
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Figure 30. Cornish-Bowden Plot of the Relaxation Reaction in the 
Presence of Norflosacin. 
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The concentration of supercoiled ~X174 DNA (s) divided by the velocity 
of the relaxation reaction (v) catalyzed by P. aeruginosa DNA gyrase is 
plotted against the concentration of nor1foxacin (1) added. ·The 
different ~in es represent different con~·gmtra ti ons of substrate: ( * ~ 
1.7 x 10- mMoles/ml, (0}.8 3.4 x 10- mMoles/ml, (O) 6.9 x 10-mMoles/ml, and(~) 1.8 x 10 mMoles/ml. 
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Figure 31. Cornish-Bowden Plot of the Relaxation Reaction in the 
Presence of Oxolinic Acid. 
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The concentration of supercoiled ~Xl74 DNA (s) divided by the velocity 
of the relaxation reaction (v) catalyzed by P. aeru inosa DNA gyrase is 
plotted against the concentration of oxol1nic ac1 1 added. The 
different g i nes represent different con~ntrations of substrate: (*~ 
1.7 x 10- mMoles/ml, (0) 83.4 x 10- mMoles/ml, (e) 6.9 x 10-mMoles/ml, and (O), 1.8x10- mMoles/ml. 
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Figure 32. Cornish-Bowden Plot of the Relaxation Reaction in the 
Presence of Nalidixic Acid. 
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10 
The concentration of supercoiled ~X174 DNA (s) divided by the velocity 
of the relaxation reaction (v) catalyzed by P. aeruginosa DNA gyrase is 
plotted against the concentration of nalidlxic acid (i) added. The 
different 9lines represent different c~ncentrations of substrate: (*~ 1.7 x 10- mMoles/ml, (0) 3.4 x 10- mMoles/ml, and (0) 6.9 x 10-
mMoles/ml. 
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Table 9. Analysis of the Covariance on the Slopes of the Cornish-Bowden Plots for Norfloxacin 
Group I Group JI Group Ill Group Iv 
x y x y x y x y SUM 
Obs I 0 5.3154 0 10.82 0 17.79 0 14.581 
Obs 2 250 6.9412 250 16.41 250 24.42 10 14.514 
Obs 3 500 7.6278 500 16.88 500 28.18 25 15.895 
Ob·s 4 750 19.83 750 34.79 50 15.101 
Obs 5 1000 35.17 75 13.368 
Obs 6 100 14.222 
Obs 7 250 16.601 
Obs 8 500 18.406 
Obs 9 750 20.484 
Obs 10 1000 25.451 
(X= 750 1500 2500 2760 7510 
(X**2= 312500 875000 1875000 1893850 ~956350 
[Y= 19.8844 63.94 140.35 168.623 392.7974 
(Y**2= 134.61706 1064.5238 4154.2059 2966.6433 8319.9901 
[XY= 5549.2 27415 81457.5 57889.615 172311.31 
Mean X= 250 375 500 276 341. 36363 
Mean"Y= 6.6281333 15.985 28.07 16.8623 17 .854427 
N= 3 4 5 10 22 
Byx= 0.0046248NS 0 .OllNS 0.018052* 0.0100254** 
Fb= 2.7313321 8.3566657 17.252357 11.825165 
f X*2-Cxx) 125000 312500 625000 1132090 
XY=Cxy 578.1 3437.5 11282. 5 11349.667 
[Y*2=Cl'.l'. 2.8206129 42.4429 214.5814 123 .27177 
Cxxw= 2194590 Cxxb= 198119 .09 Cxxt= 2392709.0 FN 1= 3 
Cxyw= 26647.767 Cxyb= 11576. 799 Cxyt= 38224.566 rn:::2= 14 
Cn!:!= 383.11668 Cub= 923.70085 cut= 1306.8175 
bw= 0.0121424 S_l= 34.372857 S_2= 25.173827 F= 6.3719620** 
Table 9. Analysis of Covariance on the Slopes of the Cornish-Bowden Plots for Norfloxacin. 
The line labelled Byx represents the slope for the individual groups. The line below, labelled Fb, 
provides the F-statistics to test whether these individual slopes differ significantly from zero. The 
critical information is the F-statistics in the lower right hand corner of the table. If that 
statistic is significant, the slopes vary significantly among the groups. The null-hypothesis assumes 
that the regress i ans based on the separate groups are the same as that based on the total group, 
except for sampling variability, and that therefore the effects of different concentrations of 
substrate can be disregarded. If the F-statistics is significant, then the slopes vary significantly 
among the groups, and from the common slope, bw, hypothesized to exist for the groups combined. The 
number in the left bottom corner is the common slope bw. Thus the hypothesis being tested is: 
b = b = b = b = b • NS indicates that a particular F-statistic is not significant, the symbol * i~dicafes trlat i~ is ~ignificant at the .05 level, and** indicates significance at the .01 level. 
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Table 10. Analysis of the Covariance on the Slopes of the Cornish-Bowden Plots for Oxolinic Acid 
Group I Group II Group III Group IV 
x y x y x y x y SUM 
Obs 1 0 13.9 125 27.6 250 54.4 0 11. 576 
Obs 2 250 15.4 375 31.6 500 66.7 10 12.212 
Obs 3 750 21.5 625 29.6 1000 70 25 12.628 
Obs 4 1000 50.8 875 38.5 75 12.486 
Obs 5 750 14.066 
Obs 6 1000 16.105 
Obs 7 
Obs 8 
Obs 9 
Obs 10 
[X= 2000 2000 1750 1860 7610 
[X**2= 1625000 1312500 1312500 1568850 5818850 
[Y= 101. 6 127.3 191.1 79.073 499.073 
[Y**2= 3473.26 4118.73 12308.25 1055.7266 20955.966 
[XY= 70775 67487.5 116950 28028.77 283241.27 
Mean X= 500 500 583.33333 310 
Mean'.:::V= 25.4 31.825 63.7 13.178833 
N= 4 4 3 6 17 
Byx= 0.03196NS 0.01228NS 0.0187714NS 0.0035436NS 
Fb= 15. 778014 10.700624 5.5211064 3.6092507 
X*2-Cxx) 625000 312500 291666.66 992250 
XY=Cxy 19975 3837.5 5475 3516.14 
Y*2=C 892.62 67 .4075 135.18 13.636792 
Cxxw= 2221416.6 Cxxb= 190839.21 Cxxt= 2412255.8 FN 1= 3 
Cxyw= 32803.64 Cxyb= 27029.069 Cxyt= 59832.709 FN-2= 9 
Cy_y_w= 1108.8442 Cy_y_b= 5195. 7188 Cy_y_t= 6304.5631 
bw= 0.0147669 s l= 316.34781 S_2= 308.08541 F= 3.0804556NS 
Table 10. Analysis of Covariance on the Slopes of the Cornish-Bowden Plots for Oxolinic Acid. 
The line l abe 11 ed Byx represents the slope for the individual groups. The 1 i ne be 1 ow, 1abe11 ed Fb, 
provides the F-statistics to test whether these individual slopes differ significantly from zero. The 
critical information is the F-statistics in the lower right hand corner of the table. If that 
statistic is significant, the slopes vary significantly among the groups. The null-hypothesis assumes 
that the regressions based on the separate groups are the same as that based on the total group, 
except for sampling variability, and that therefore the effects of different concentrations of 
substrate can be disregarded. If the F-statistics is significant, then the slopes vary significantly 
among the groups, and from the common slope, bw, hypothesized to exist for the groups combined. The 
number in the left bottom corner is the common slope bw. Thus the hypothesis being tested is: 
b = b = b = b = b • NS indicates that a particular F-statistic is not significant, the symbol * 
iAdicates t~at if is ~ignificant at the .05 level, and** indicates significance at the .01 level. 
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Table 11. Analysis of Covariance on the Slopes of the Cornish-Bowden Plots for Nalidixic Acid 
Group I Group II Group II I 
x y x y x y SUM 
Obs 1 0 6.8 0 13.5 0 30 .144 
Obs 2 500 7.4 250 14.3 125 31.368 
Obs 3 750 7.52 500 16.6 375 35.6856 
Obs 4 1000 29.92 750 14.8 625 33.7392 
Obs 5 
Obs 6 
Obs 7 
Obs 8 
Obs 9 
Obs 10 
f x- 2250 1500 1125 4875 X**2= 1812500 875000 546875 3234375 
[Y= 51.64 59.2 130.9368 241. 7768 
[Y**2= 1052.7568 881.34 4304.4078 6238.5046 
[XY= 39260 22975 38390.1 100625.1 
Mean'-X= 562.5 375 281. 25 
Mean-Y= 12.91 14.8 32.7342 
N= 4 
0.0186742NS 
4 
0.00248NS 
4 
0.0067867NS 
12 
Byx= 
Fb= 9.4048879 4.3387025 3.3488856 
f X*2=Cxx 546875 312500 230468.75 
XY=Cxy 10212.5 775 1564.125 
[Y*2=Cu 386.0844 5.18 18.296425 
Cxxw= 1089843.7 Cxxb= 164062.5 Cxxt= 1253906.2 FN 1= 3 
Cxyw= 12551. 625 Cxyb= -10148.35 Cxyt= 2403.275 FN-2= 4 
C~y_w= 409.56082 Cy_y_b= 957 .60871 C~y_t= 1367.1695 
bw= 0.0115169 s 1= 58.692558 s 2= 206.31241 F= 0.3793118NS 
Table 11. Analysis of Covariance on the Slopes of the Cornish-Bowden Plots for Nalidixic Acid. 
The 1 i ne 1abel1 ed Byx represents the s 1 ope for the i ndi vi du a 1 groups. The 1 i ne be 1 ow; 1 abel led Fb, 
provides the F-statistics to test whether these individual slopes differ significantly from zero. The 
critical information is the F-statistics in the lower right hand corner of the table. If that 
statistic is significant, the slopes vary significantly among the groups. The null-hypothesis assumes 
that the regressions based on the separate groups are the same as that based on the total group, 
except for sampling variability, and that therefore the effects of different concentrations of 
substrate can be disregarded. If the F-statistics is significant, then the slopes vary significantly 
among the groups, and from the common slope, bw, hypothesized to exist for the groups combined. The 
number in the left bottom corner is the common slope bw. Thus the hypothesis being tested is: 
b = b = b = b = b • NS indicates that a particular F-statistic is not significant, the symbol * i~dicates tKat i~ is ~ignificant at the .05 level, and** indicates significance at the .01 level. 
Table 12. Analysis of Covariance on the Slopes of the Cornish-Bowden Plots for Norfloxacin 
at Higher Substrate Concentrations Only 
Group Group I I Group III 
x y x y x y SUM 
Obs 1 0 5.3154 0 10.82 0 17.79 
Obs 2 250 6.9412 250 16.41 250 24.42 
Obs 3 500 7.6278 500 16.88 500 28.18 
Obs 4 750 19.83 750 34.79 
Obs 5 1000 35.17 
Obs 6 
Obs 7 
Obs 8 
Obs 9 
Obs 10 
(X= 750 1500 2500 4750 
~X**2= 312500 875000 1875000 3062500 
Y= 19.8844 63.94 140.35 224.1744 
P**2= 134.61706 1064.5238 4154.2059 5353.3467 
XY= 5549.2 27415 81457.5 114421. 7 
Mean"-X= 250 375 500 
Mean-Y= 6.6281333 15.985 28.07 
N= 3 4 5 12 
Byx= 0.0046248NS 0.011NS 0.018052* 
Fb= 2.7313321 8.3566657 17.252357 
[X*2=Cxx 125000 312500 625000 
(XY=Cxy 578.1 3437.5 11282. 5 
[Y*2=C,U 2.8206129 42.4429 214.5814 
Cxxw= 1062500 Cxxb= 119791.66 Cxxt= 1182291.6. FN l= 3 
Cxyw= 15298.1 Cxyb= 10387.9 Cxyt= 25686 FN-2= 4 
Cy_y_w= 259.84491 Cn:b= 905.65505 Cn:t= 1165.499 
bw= 0.0143982 s l= 23.892503 S_2= 15.687126 F= 2.0307525NS 
Table 12. Analysis of Covariance on the Slopes of the Cornish-Bowden Plots for Norfloxacin 
at Higher Substrate Concentrations Only 
The line labelled Byx represents the slope for the individual groups. The line below, labelled Fb, 
provides the F-statistics to test whether these individual slopes differ significantly from zero. The 
critical information is the F-statistics in the lower right hand corner of the table. If that 
statistic is significant, the slopes vary significantly among the groups. The null-hypothesis assumes 
that the regressions based on the separate groups are the same as that based on the total group, 
except for sampling vari abi 1 ity, and that therefore the effects of different concentrations of 
substrate can be disregarded. If the F-statistics is significant, then the slopes vary significantly 
among the groups, and from the common slope, bw, hypothesized to exist for the groups combined. The 
number in the left bottom corner is the common s 1 ope bw. Thus the hypo thesis being tested is: 
b1 = b = b = b = b . NS indicates that a particular F-statistic is not significant, the symbol * indica~es t~at it is ~ignificant at the .05 level, and** indicates significance at the .01 level. 
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Figure 33. Plot of the Velocity of the Relaxation Reaction in the 
Presence of Novobiocin. 
The velocity of the relaxation reaction catalyzed by P. aeruginosa DNA 
gyrase is plotted against the concentration of novobiocln (i) added. 
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CATENATION REACTION 
An agarose gel of the products from the supercoiling reaction 
exhibited a band of lower electrophoretic mobility (Figure 34). This 
band may consist of concatamers of the circular DNA, since catenated 
circular DNA has been shown to have lower electrophoretic mobility than 
relaxed DNA on an agarose gel (42). This band may not be due to protein 
bound DNA since these reactions were extracted with a mixture of 
chloroform and isopropanol before loading the gel. 
CLEAVAGE OF DNA 
Incubation of DNA gyrase with pyridonecarboxylic acid for one hour 
at 37° C with subsequent incubation in the presence of SOS resulted in 
cleavage of the relaxed and linear DNA with little if any cleavage of 
the supercoiled DNA (Figure 35, lanes 3-8). ATP (lane 7) and AppNp 
(lane 8) did not prevent the cleavage but inhibited it slightly. The 
DNA migrated to the same distance in the presence and absence of 
proteinase K digestion (lanes 3 and 4, respectively). This suggests 
that no protein is attached to the cleaved DNA, but the gel may not be 
sensitive enough to show the slight difference in migration. The fact 
that the cleavage product consists of two bands (which are hard to 
distinguish in Figure 35 but can be seen in the densitometric tracing) 
which migrate faster than linear DNA (lane 10) indicates that DNA gyrase 
cleaves the DNA in two places. 
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Figure 34. The Catenation Reaction of ~· aeruginosa DNA Gyrase. 
P. aeru~inosa DNA gyrase was incubated with relaxed ~X174 DNA as 
describe for the supercoiling reaction in the Methods section. Lane 1 
contains relaxed DNA incubated in the absnece of DNA gyrase and lane 9 
contains supercoiled DNA. Lanes 2-8 contain relaxed DNA incubated with 
one unit of DNA gyrase. 
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Figure 35. Cleavage of DNA by ~· aeruginosa DNA Gyrase in the Presence 
of Pyridonecarboxylic Acid and SOS. 
The 0X174 DNA used in this reaction is seen in lane 1, the upper band is 
relaxed, closed circular DNA, the middle band is linear DNA, and the 
1 ower band is supercoil ed DNA. When this DNA is incubated with P. 
aeruginosa DNA gyrase in the absence of drug, a ladder of bands between 
the linear and supercoiled which consists of different topoisomers 
differing by two linking numbers can be seen (lane 2). When the DNA is 
incubated with pyridonecarboxylic acid followed by incubation in the 
presence of SOS as described in the text, two bands (which are hard to 
distinguish in this photograph) consisting of cut linear DNA can be seen 
(lanes 3-8). Norfloxacin (lanes 3 and 4), nalidixic acid (lane 5), 
oxolinic acid (lanes 6-9) or novobiocin (lane 9) was used. Proteinase K 
(lane 5), ATP (lane 7) or AppNp (lane 8) was added to the reaction as 
described in the text. Linear 0X174 DNA is in lane 10. The inset is a 
densitometric tracing of lane 3. R is the distance migrated by 
completely relaxed DNA and S is the distance migrated by completely 
supercoiled DNA. 
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ATPase REACTION 
ATP hyrolysis was examined by measuring the amount of inorganic 
phosphate released during the supercoiling reaction. This was detected 
by reading the absorbance at 660 nanometers (A660 ) of the supercoi 1 i ng 
reaction mixture incubated at 37° C for 30 minutes and treated with 
co 1 or reagents as described in the Methods sect ion. The A660 of the 
supercoiling reaction mixture was not significantly different from the 
A660 of the controls lacking DNA gyrase or ATP (Table 13). The A660 of 
the inorganic phosphate standards was directly proportional to the 
concentration of inorganic phosphate (Figure 36). No ATPase activity 
was detected in either fresh or frozen DNA gyrase preparations. One 
unit of M. luteus DNA gyrase (Bethesda Research Laboratories) and 
incubated in the supercoiling reaction mixture containing 0.5 micrograms 
of relaxed 9JX174 DNA exhibited detectable ATPase activity (2 x 10-6 
moles of inorganic phosphate released per minute) which was inhibited by 
10 micrograms/ml of novobiocin. 
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Table 13. ATPase Reaction 
Experiment Sample OD660 
P. aeruginosa DNA gyrase: 
1 Supercoiling reaction 3.142 +/- 0.009 
Control, no DNA gyrase 3.224 +/- 0.003 
Control, no ATP 3.284 +/- 0.003 
2 Supercoiling reaction 2.821 +/- 0.089 
Control, no DNA gyrase 2.850 +/- 0.021 
Control, no ATP 2.862 +/- 0.013 
3 Supercoiling reaction 2.067 +/- 0.062 
Control, no DNA gyrase 2.098 +/- 0.093 
Control, no ATP 2.054 +/- 0.009 
4 Supercoiling reaction 2.015 +/- 0.013 
Control, no DNA gyrase 2.098 +/- 0.093 
Control, no ATP 2.017 +/- 0.011 
5 Supercoiling reaction 2.954 +/- 0.022 
Control, no DNA gyrase 2.979 +/- 0.018 
Control, no ATP 2.986 +/- 0.052 
M. luteus DNA gyrase: 
1 Supercoiling reaction 3.180 +/- 0.024 
Control, no DNA gyrase 2.979 +/- 0.028 
Control, no ATP 2.986 +/- 0.052 
Supercoiling reaction + 3.077 +/- 0.033 
novobiocin* 
*10 micrograms/ml 
* 25 
* 
20 
0 
°'o 15 * 
°' Cl 
. 10 
5 
I I 
2 4 6 8 10 
Phosphate tic 104 Molarl 
Figure 36. Calibration Curve for the Concentration of Inorganic 
Phosphate. 
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DISCUSSION 
IN VIVO EFFECTS OF PYRIDONECARBOXYLIC ACIDS ON P. AERUGINOSA 
Pseudomonas aeruginosa is more resistant to norfloxacin and 
nalidixic acid than Escherichia coli {Table 9 and reference 30). These 
two pyridonecarboxylic acid derivatives affect f. aeruginosa similarly, 
since spontaneous mutants resistant to norfloxacin, RM166, 167, 168, and 
169, are also resistant to nalidixic acid, and a nalidixic acid 
resistant mutant, RM4000, is also resistant to norfloxacin (Table 9). 
This suggests that the two derivatives have the same mechanism of 
transport into the cell, they have the same target of action, or both. 
Since pyridonecarboxyl ic acids inhibit ~· coli DNA gyrase and a 
nalidixic acid-sensitive DNA gyrase has been purified from f. aeruginosa 
{56), the site of action of these drugs is most likely DNA gyrase bound 
to the chromosome. DNA gyrase is required for DNA replication {36) and 
pyridonecarboxylic acids inhibit DNA synthesis {22,25). Therefore, it 
would be expected that these drugs would be most potent when DNA 
replication is most active and when the activities of DNA gyrase are 
clearly needed in early to mid-log phase of an logarithmically growing 
culture, and less potent when there is little if any DNA replication in 
late log phase. Treatment of a culture of f. aeruginosa in early log 
phase with norfloxacin causes a significant inhibition of growth {Figure 
4). Treatment of this culture in ·1ate log phase causes much less 
inhibition of growth {Figure 5). 
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P. aeruginosa cultures treated with bactericidal concentrations of 
pyridonecarboxylic acids exhibit lethal unbalanced growth. This is a 
deregulation of the normal growth cycle where cells that are no longer 
viable undergo cell division and filamentation. Filamentation is an 
elongation of the cell which keeps the surface to volume ratio constant. 
This allows the extra chromosomes synthesized in the absence of ce 11 
division to be distributed along the cell membrane. Both PA0303 and RMB 
exhibit cell division after 24 hours of treatment with norfloxacin or 
nalidixic acid and RMB filaments when treated with nalidixic acid 
(Figure B). This lethal unbalanced growth may result from the 
prevention of the completion of a round of chromosome replication by 
pyridonecarboxylic acids since this completion has been suggested to 
trigger the initiation of septation which precedes cell division (15). 
Pyridonecarboxylic acids may prevent the induction of a cell division 
regulating signal by preventing the completion of a round of chromosome 
replication. 
Alternatively, lethal unbalanced growth may result from 
pyridonecarboxylic acids effect on gene expression (reviewed in lB). 
Treatment with pyridonecarboxylic acids causes a decrease in the 
synthesis of outer membrane proteins in comparison to the synthesis of 
inner membrane proteins ( 2B). Si nee a sudden exponent i a 1 increase in 
the synthesis of outer membrane proteins has been observed just before 
cell division (4), pyridonecarboxylic acids could deregulate the cells 
growth cycle by inhibiting the expression of outer membrane proteins. 
Also, these drugs may alter the expression of a protein which regulates 
cell division and thus allowing some bf the cells to divide even though 
the division would not result in two viable cells. Therefore, the 
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mechanism of drug induced cell death may be the inhibition of the 
expression of specific genes which are vital to the cell. 
The bactericidal activity of pyridonecarboxylic acids in ,;_. coli 
has been shown to require competent RNA and protein synthesis (76,84). 
Simultaneous treatment of P. aeruginosa with chloramphenicol or 
rifamycin, inhibitor of protein and RNA syntheses, respectively, along 
with pyridonecarboxylic acid alleviates the bactericidal effect of the 
pyridonecarboxylic acid (Figures 6A and 7A). This protection suggests 
that there may be a gene responsible for killing whose expression is 
induced upon drug treatment and therefore, by preventing the expression 
of this gene, chloramphenicol prevents killing. 
RECOVERY SYNTHESIS 
In a logarithmically growing culture, the rate of DNA synthesis as 
followed by pulse labeling DNA increases logarithmically (Figure 11). 
Pyridonecarboxylic acid treatment causes an immediate inhibition of the 
rate of DNA synthesis. Within 5 minutes, however, the rate of DNA 
synthesis is again increasing logarithmically. I will term this second 
exponential rate of DNA synthesis "recovery synthesis." Recovery 
synthesis is observed at concentrations below the MBC and not at the 
MBC. 
Pyridonecarboxylic acids may act by binding to DNA at sites 
complexed with DNA gyrase thereby creating complexes that block the 
movement of the replication fork (19). Also, these drugs inhibit- the 
activities of DNA gyrase which is part of the enzyme system required for 
replication (36). Therefore, in order for recovery synthesis to occur, 
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a repair system to remove the hypothesized drug-DNA gyrase complex and 
repair the DNA may be needed. Recovery synthesis may also require the 
synthesis of new DNA gyrase molecules to replace those inactivated by 
drug. 
If recovery synthesis results from an inducible repair system, then 
simultaneous treatment with drug and chloramphenicol, an inhibitor of 
protein synthesis, will prevent the synthesis of the necessary proteins 
and recovery synthesis should not be observed. Simultaneous treatment 
with pyridonecarboxylic acid and chloramphenicol does prevent recovery 
synthesis in PA0303 (Figure 13A). In this case, the initial rapid rate 
of inhibition of DNA synthesis is followed by a slower rate of 
inhibition. When these cultures are treated with chloramphenicol alone, 
the rate of DNA synthesis also decreases. This suggests that the 
enzymes required for the exponential rate of DNA synthesis must be 
continually synthesized. 
The fact that protein synthesis is required for both killing and 
recovery synthesis suggests that the induced genes which are responsible 
for these two phenomena may be under the same control or in fact may be 
the same gene. Perhaps it is the DNA gyrase gene itself. Since DNA 
gyrase is required for DNA replication, it follows that it would also be 
required for recovery synthesis because DNA synthesis occurs during both 
recovery synthesis and DNA replication. Synthesis of new DNA gyrase 
molecules in a pyridonecarboxylic acid treated cell may be lethal since 
this would result in more drug-DNA gyrase complexes on the chromosome 
which will inhibit replication. Also, the synthesis of new DNA gyrase 
molecules may alter the superhelical density of the chromosome and 
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result in a greater effect on gene expression which could be lethal to 
the cell. 
THE MECHANISM OF RECOVERY SYNTHESIS 
What happens inside a f. aeruginosa cell in the five minutes it 
takes to overcome the inhibiting effects of pyridonecarboxylic acids and 
start recovery synthesis? How are the drug-DNA gyrase complexes removed 
from the DNA? Is more DNA gyrase synthesized, or can the old DNA gyrase 
molecules be freed from the pyridonecarboxylic acids? 
In order to answer some of these questions, the effects of 
pyridonecarboxylic acids on P. aeruginosa mutants deficient in 
recombination (a Rec- phenotype) were also studied; PA02002, a Rec-
mutant of PA02001, which is less resistant to nalidixic acid than its 
parent and RMB, a Rec- mutant of PA0303, which is more resistant to 
norfloxacin and nalidixic acid than its parent. If a recombinational 
DNA repair system were used to remove drug-DNA gyrase complexes, then 
recovery synthesis would not be observed in ·these mutants. These 
mutants are of interest to study a 1 so because they are deficient in 
lysogeny establishment of phage (a Les- phenotype) and DNA gyrase is 
required for lysogenic establishment of prophage lambda into the E. coli 
chromosome (57). 
As expected, PA02002 (Rec-) does not exhibit recovery synthesis 
(Figure 148 and D). After a five minute initial phase of rapid 
inhibition, the rate of DNA synthesis decreases at a slower rate. 
Biphasic inhibition kinetics is also observed when PA0303 is treated 
simultaneously with pyridonecarboxylic acid and chloramphenicol (Figure 
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13A): an initial rapid rate of inhibition is followed by a slower rate 
of inhibition. 
Why are there two distinct rates of inhibition in the absence of 
recovery synthesis as in the case of PA02002 and chloramphenicol-treated 
PA0303? If DNA gyrase binds to DNA approximately every 100 ki l obase 
pairs (17), then the replications forks would stop whenever they reached 
a drug-DNA gyrase complex that had not yet been removed and monophasic 
inhibition kinetics would be expected. But there is evidence that DNA 
gyrase binds at or near the replication forks in addition to binding 
approximately every 100 kilobasepairs and this could explain the 
biphasic inhibition kinetics (17). The initial rapid rate of inhibition 
may be due to drug-DNA gyrase complexes occurring at the replication 
fork. The slower rate of inhibition may be the result of replication 
forks which escaped the drug proceeding until they reached a drug-DNA 
gyrase complex on the DNA or until the terminus of replication. 
From the hypothesis that the initial inhibition is due to drug-DNA 
gyrase complexes occurring at the replication fork, it would follow that 
one can titrate replication forks on DNA with the drug-DNA gyrase 
comp 1 exes. If this is true, then one would expect that for a given 
bacterial strain, the degree of inhibition should be the same for both 
norfloxacin and nalidixic acid provided the concentrations of both drugs 
is sufficiently high (e.g., four times the MIC). As seen in Figures 11 
and 12, at a concentration of four times the MIC, nalidixic acid 
initially inhibits DNA synthesis to a greater extent than norfloxacin. 
The MIC's for norfloxacin and nalidixic acid are very different. 
This may be due to the fact that the· drugs' effects on other processes 
besides DNA synthesis are involved in the inhibition of growth. The 
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concentration at which RNA and protein synthesis are inhibited most 
likely also play a role in the minimal concentration required to inhibit 
growth because the concentration at which RNA and protein synthesis are 
inhibited is greater than the concentration at which DNA synthesis is 
inhibited (76). The inhibition of protein synthesis may play a role in 
the rate of DNA synthesis because enzymes involved in DNA synthesis need 
to be made. Also, since release of RNA from the chromosome requires 
translation in a prokaryotic cell (48), drug-inhibited translation may 
block replication. Since nalidixic acid and norfloxacin inhibit protein 
synthesis to different extents at the concentration of four times the 
MIC (Figure 9), the same extent of DNA synthesis inhibition is not 
expected for this concentration of each drug. Since nal idixic acid 
inhibits protein synthesis to a greater extent than norfloxacin, it 
would be expected to have a greater effect on DNA replication than 
norfloxacin. Norfloxacin would be expected to have a greater initial 
inhibitory effect on DNA replication if protein synthesis was inhibited 
simultaneously with norfloxacin treatment. This is observed by 
comparing the initial inhibitions in Figure 11 and 13. This data is 
summarized in Table 14. 
The biphasic inhibition kinetics can also be explained another way. 
Perhaps the initial rapid rate of inhibition is due to the inactivation 
of DNA gyrase on the chromosome causing an immediate stop to the 
existing rep 1 i ca ti on forks. DNA synthesis during the second phase is 
1 imited to DNA stretches unbound by drug-DNA gyrase mo 1 ecul es and can 
only utilize the activity of the DNA gyrase complexes left unaffected by 
the drug. The creation of new replication forks is probably required 
for this second phase. In the case of the Rec- mutant, recovery 
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Table 14. Initial Inhibitions (percent) 
Strain Nalidixic Norfloxacin Norfloxacin and 
acid Chloramphenicol 
PA 0303 80 50 60 
RMB 75 30 40 
PA02001 85 30 ND 
PA02002 80 40 ND 
This data is summarized from Figures 11 t 12, 13, and 14. 
ND = Not determined. 
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synthesis does not occur because the drug-DNA gyrase complexes are not 
being removed from the chromosome. In the case of PA0303 treated 
simultaneously with chloramphenicol and pyridonecarboxylic acid, 
recovery synthesis does not occur because new DNA gyrase molecules can 
not be synthesized. 
RMB: A SPECIAL CASE 
The other Rec- mutant RMB surprisingly exhibited recovery synthesis 
in the presence of norfloxacin (Figure 118). It also exhibited recovery 
synthesis in the presence of nalidixic acid, but this recovery synthesis 
could not be sustained (Figure 128). Since nalidixic acid inhibits 
protein synthesis about 99%, it probably does not allow the synthesis of 
large enough quantities of the required enzymes to support recovery 
synthesis. Since norfloxacin inhibits protein synthesis only about 50%, 
it a 11 ows the synthesis of enough of the required enzymes to support 
recovery synthesis. 
If recombination is required for recovery synthesis, then why does 
recovery synthesis occur in RMB if it is deficient in recombination, 
while the other Rec- strain (PA02002) does not exhibit recovery 
synthesis? It is very likely that some of the enzymes involved in 
recombination are also actively involved in recovery synthesis as well 
and if RMB is deficient .in these enzymes, then it should also be 
deficient in recovery synthesis. The recombinational deficiency in RMB 
may not be due to lacking or inactive recombinational enzymes. Perhaps 
RMB is different from the wild type cell because it constitutively 
synthesizes a low amount of the necessary enzymes which may be enought 
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for some recovery synthesis to occur but not enough for recombination, 
whereas its parent, PA0303, only synthesizes these enzymes upon 
induction by pyridonecarboxylic acids (Figures llA, 12A, and 13A). To 
test this, RM8 was treated simultaneously with chloramphenicol and 
norfloxacin. In this case, recovery synthesis occurred but could not be 
sustained (Figure 138). The DNA synthesis curve looked very similar to 
the DNA synthesis curve of nalidixic acid alone (Figure 128). By 
inhibiting protein synthesis at the same time as treatment with 
norfloxacin, the effects of nalidixic acid were mimicked. This supports 
the previously mentioned data that nalidixic acid inhibits protein 
synthesis 99%, while norfloxacin inhibits protein synthesis only about 
50% (Figure 9). 
If inhibition of protein synthesis prevents recovery synthesis, 
then why does recovery synthesis occur in PA0303 treated with nalidixic 
acid if nalidixic acid inhibits protein synthesis 99%? Chloramphenicol 
inhibits initiation of protein synthesis while allowing elongation of 
previously initiated amino acid chains to continue. It is not known how 
nalidixic acid inhibits protein synthesis. Nalidixic acid may inhibit 
protein synthesis by inhibiting elongation of amino acid chains since 
the full inhibitory effect of this drug is not felt until 10 minutes 
after treatment. (Figure 9). Under this hypothesis, the induced proteins 
will be initiated and elongation of enough proteins to perform recovery 
synthesis might occur in the presence of nalidixic acid. Small 
concentrations of these proteins may be sufficient to perform recovery 
synthesis, since the low levels of these proteins postulated to be 
present in RM8 are sufficient for recovery synthesis but not sufficient 
to make this strain recombinationally proficient. 
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Thus, PA02001 and PA0303 exhibit recovery synthesis because they 
synthesize the required enzymes upon induction by drug. The required 
enzymes inc 1 ude at 1 east some of the enzymes that a re involved in 
recombination. PA02002 may not exhibit recovery synthesis because its 
recombination enzymes are inoperative or lacking. RMB may synthesize 
recombination enzymes at levels too low for this strain to be considered 
recombinationally proficient, but in the presence of sufficient protein 
synthesis, enough of these enzymes may be made to a 11 ow some recovery 
synthesis to occur. 
The enzymes involved in both recombination and recovery synthesis 
most likely would contain exonuclease and polymerase activities if the 
recovery mechanism is to cut out pieces of DNA bound by drug-DNA gyrase 
complexes. Alternatively, the enzymes may contain supercoiling activity 
that may cause the complex to fall off the chromosome. This may be 
true, since gyrase binds less well to supercoiled DNA than to relaxed. 
The bactericidal activity of pyridonecarboxylic acids in RMB is not 
alleviated by inhibiting protein or RNA synthesis simultaneously with 
drug treatment (Figures 68 and 78, respectively}. This suggests that 
the protein(s} responsible for killing is present before drug treatment. 
The observation that RMB naturally has a high percentage of dead cells 
(56} supports this hypothesis. Since PA0303 synthesizes the protein 
responsible for killing only upon induction (Figures 6A and 7A}, the 
observation that killing in RMB is not alleviated by chloramphenicol 
supports the hypothesis that RMB 1 s mutation is constitutive. 
RMB filaments when treated with nalidixic acid but not when treated 
with norfloxacin (Figure BD and F). This is surprising, since nalidixic 
acid inhibits protein synthesis to a greater extent than does 
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norfloxacin (Figure 9). This supports the hypothesis that filamentation 
is caused by a more complex mechanism than the mere inhibition of 
replication in the presence of continued RNA and protein synthesis. 
INDUCTION OF DNA REPAIR 
Treatment of E. coli with nalidixic acid has been shown to induce 
- --
the synthesis of the RecA protein (25,26), which controls the expression 
of and/or is involved in all of the dark DNA repair pathways known to 
exist in E. coli (82). Nalidixic acid treatment also induces a 
mutagenic repair pathway in£_. coli that will repair UV-damaged phage 
DNA (69). This is detected by infecting nalidixic acid-treated cells 
with UV-damaged phage and determining how many phage survive. If a DNA 
repair pathway has been induced by the drug treatment, then the number 
of PFU 1 s in the treated culture will be exponentially greater than the 
number of PFU 1 s in the control untreated culture. The DNA repair 
pathway induced in £_. coli is mutagenic, because the number of plaques 
with altered phenotypes found among the reactivated plaques is in 
proportion to the extent of reactivation (69). 
Similar results would be expected when these experiments are 
repeated with E· aeruginosa, since E· aeruginosa possesses a ~ 
protein which restores Rec+ phenotypes to Rec- E. coli cells (42). 
Neither norfloxacin nor nalidixic acid induced increased repair or 
mutagenesis of UV-damaged phage D3 in PA0303 or RM8 (Figure 16). This 
is not completely unexpected, however, since ultraviolet irradiation 
does not induce repair or mutagenesis of UV-damaged phage D3 in these 
strains either (72). Speculation on the method used to remove drug-DNA 
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gyrase complexes from the chromosome in f. aeruginosa must await further 
knowledge of the f. aeruginosa DNA repair pathways. 
P. AERUGINOSA DNA GYRASE AND TOPO 11' 
Even though pyridonecarboxylic acids bind to DNA instead of DNA 
gyrase (70), their ultimate effect is to i_nhibit the activities of the A 
subunit and DNA gyrase (22). Therefore, in order to further study the 
mechanism of action of pyridonecarboxyl ic acids in f. aeruginosa, I 
isolated DNA gyrase from strain PA0303 and tested the in vitro effects 
of these drugs on the purified preparation. 
f. aeruginosa DNA gyrase has been isolated previously by Miller and 
Scurlock (56), who used a series of three columns for the purification. 
After minimal success with this method, I attempted to adapt the method 
of Staudenbauer et !!_. (76). Using a novobioci n-Sepharous affinity 
column, I was able to improve the specific activity from 15,000 units/mg 
protein to 37,000 units/mg protein. 
P. aeruginosa DNA gyrase protein is similar to the ~· coli DNA 
gyrase protein in that it consists of two subunits with molecular 
weights of approximately 95,000 and 105,000 (Figure 17). Since the 
molecular weight of the holoenzyme is 3.6 ~ .3 x 105 (50), it most 
likely consists of two molecules of each of the two subunits. Two lower 
molecular weight proteins are also present in the purified preparation 
at lower concentrations. I suspect that these other proteins may be 
proteolytic products of the B subunit similar to the~- coli v subunit 
of topo 11' for the following reasons: 
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1. No ATPase activity was detected in the DNA gyrase preparation 
{Table 13), and£. coli topo II' has no ATPase activity. 
2. ATP does not alter the DNA cleavage pattern within the limits of 
detection available in the system used {Figure 35). ATP is known 
to alter the cleavage pattern of DNA gyrase but not of topo II' in 
E. coli. 
- --
3. After freezing or after 24 hours of storage at 4° C, the DNA gyrase 
preparation loses its supercoil ing activity and only cleaves the 
DNA with a double-stranded cut without completing the reaction 
{Figures 19 and 22). In£. coli, DNA gyrase cleaves less than one 
percent of the DNA in a supercoiling reaction mixture {77), and 
topo II' cleaves all of the effected DNA molecules (6). 
4. In attempting to observe inhibition of the supercoiling reaction, 
supercoiling was observed in samples containing pyridonecarboxylic 
acid concentrations as high as the MBC, while no supercoiling 
activity was observed in the absence or in the presence of low 
concentrations of these drugs. This indicates that the relaxing 
activity of topo II' is greater than the supercoiling activity of 
.ONA gyrase in my preparation and that this relaxing activity is 
more sensitive to drug than the supercoiling activity. At 
concentrations as high as the MBC, topo II' is inhibited enough to 
allow the supercoiling activity of DNA gyrase to be detected. 
There may be contaminating proteases in my preparation that cleaves 
the B subunit into a v-like subunit or the B subunit may be less stable 
than the v-like subunit perhaps due to improper renaturation after urea 
treatment. However the B subunit is cleaved, it appears that it is 
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cleaved in the portion of the protein that contains the ATPase activity 
leaving the portion of the protein that interacts with the A subunit 
intact. If it could no longer interact with the A subunit, then the DNA 
cleavage reaction most likely would not be observed since the A subunit 
off. coli DNA gyrase does not cleave DNA in the absence of the B or v 
subunit and site specific cleavage is observed in my preparation 
(Figures 20, 22, and 35). 
The activities of f. coli and P. aeruginosa DNA gyrase are also 
similar. E· aeruginosa DNA gyrase supercoil relaxed closed circular DNA 
in an ATP-dependent reaction (Figures 19 and 21). It relaxes negatively 
supercoiled ONA in the absence but not in the presence of ATP (Figure 
24). Also, incubating the enzyme with DNA and norfloxacin, nalidixic 
acid, or oxolinic acid followed by incubation in the presence of SOS, 
results in cleavage of DNA (Figure 35, lanes 3, 5, and 6, respectively). 
Cleavage occurs in the presence and absence of ATP (lane 7) and AppNp (a 
nonhydrolyzable analog of ATP, lane 8), and does not occur if 
pyridonecarboxylic acid is absent or if novobiocin (a B subunit 
inhibitor) is used instead (lane 10). E· aeruginosa DNA gyrase also 
catentates closed circular DNA in the presence of spermidine and ATP 
(Figure 34). E· aeruginosa DNA gyrase is different from f. coli DNA 
gyrase in that it has no detectable ATPase activity. This may not be 
real however since the supercoiling activity is very unstable and E. 
coli DNA gyrase isolated using the same procedure has similar problems 
with supercoiling in my system (Figure 18). In fact, the two DNA 
gyrases may not be different at all. 
Since pyridonecarboxylic acids are inhibitors of the A subunit of 
DNA gyrase (10,22,24) and inhibition of P. aeruginosa DNA gyrase 
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catalyzed supercoiling by nalidixic acid and novobiocin has already been 
shown (56), the relaxation activity was examined in detail. The K for 
m 
relaxation is 1.1 +/- 0.5 x 10-9 Molar (M). This relaxation activity 
was inhibited by pyridonecarboxyl ic acids, but not novobiocin (Figure 
17). The more potent derivative, norfloxacin, has a smaller Ki (2.0 x 
10-3 M) than the less potent oxolinic acid (K; = 3.7 x 10-3 M). 
Nalidixic acid, which is the least potent, has the largest Ki which is 
10.8 x 10-3 M. This indicates that the mechanism of action of 
pyridonecarboxylic acids involves their inhibition of DNA gyrase, since 
the more potent derivatives inhibit DNA gyrase to a greater extent. 
Also, the more potent inhibitors of the supercoiling reaction have a 
higher affinity for DNA (70). 
The five fold difference in Ki's does not completely explain the 
100 fold difference in the MIC's and MBC's. The greater inhibition of 
protein synthesis by nalidixic acid over norfloxacin may also contribute 
to the lower potency of nalidixic acid as compared to norfloxacin 
because inhibition of protein synthesis overcomes the bactericidal 
activity of these drugs. The difference in MIC's and MBC's may also be 
due· to different efficiencies of transportation into the cell, 
differences in metabolism of the drugs, and possible toxic effects of 
the metabolic products. No matter how these drugs inhibit DNA gyrase, 
either indirectly by binding to DNA or by inhibiting DNA gyrase 
directly, the more potent inhibitors have a greater bactericidal 
activity. 
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MECHANISM OF INHIBITION OF DNA GYRASE 
Pyridonecarboxylic acids act by binding to DNA (70). Therefore, by 
increasing the concentration of DNA for a certain drug concentration at 
a set volume, the ratio of drug bound per unit length of DNA will be 
decreased. This will result in a lesser extent of inhibition of subunit 
A activity at the higher substrate (DNA) concentrations. As can be seen 
in Figures 27, 28, and 29, the relaxation reactions carried out at 
higher substrate concentrations have greater velocities (less 
inhibition, smaller 1/v values) for the same concentrations of 
pyridonecarboxylic acids. 
In order to understand the mechanism of inhibition of DNA gyrase by 
pyridonecarboxylic acids, the question of whether or not the drug ever 
comes in actual physical contact with the enzyme must first be answered. 
In other words, do these drugs inhibit DNA gyrase indirectly by 
interacting with DNA or directly by forming a complex with DNA gyrase 
and DNA? The binding experiments of Shen et ~· (64) indicate that the 
drug does not bind directly to£. coli DNA gyrase. However, cleavage of 
DNA by DNA gyrase in the presence of SOS and drug, but not in the 
absence of drug, suggests that the drug does eventually come in physical 
contact with the enzyme. The drug most likely traps a reaction 
intermediate in which the enzyme is covalently attached to the DNA. 
Also, oxolinic acid inhibits the specific binding of DNA gyrase to ort, 
but does not inhibit the arbitrary binding spread throughout the rest of 
the DNA molecule (50). The data mentioned above suggest that the 
inhibition of DNA gyrase by pyridonecarboxylic acids results from the 
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initial binding of drug to DNA followed by physical contact of DNA 
gyrase with the drug-DNA complex. 
Since pyridonecarboxylic acids bind to the substrate (DNA) and not 
the enzyme (DNA gyrase), it is unlikely that these drugs exert 
noncompetitive or mixed inhibition on the relaxation reaction, because 
noncompetitive inhibitors interfere with the catalytic properties of the 
enzyme while having no effect on the binding of the substrate, and mixed 
inhibitors bind both to the free enzyme and the enzyme substrate 
complex. Also, the inhibition exerted by noncompetitive inhibitors is 
independent of the ratio of inhibitor concentration to substrate 
concentration and increasing the substrate concentration causes a 
decrease in the extent of inhibition for a given pyridonecarboxylic acid 
concentration (Figures 27, 28, and 29). Pyridonecarboxylic acids may 
not exert uncompetitive inhibition on the relaxation reaction, because 
uncompetitive inhibitors bind only to the enzyme-substrate complex, and 
not to the free enzyme. Since pyridonecarboxylic acids bind to 
substrate in the absence of enzyme, their effects (if any) on the 
association of enzyme and substrate would not be considered in 
uncompetitive inhibition. The most likely type of inhibition exerted by 
these drugs would be the competitive type, because competitive 
inhibitors exert their effect before the association of the enzyme and 
substrate. 
depends on 
Also, in competitive inhibition, the degree of inhibition 
the ratio of inhibitor concentration to substrate 
concentration and, as mentioned previously, decreasing this ratio causes 
a decrease in the extent of inhibition. 
I propose three models for the inhibition of DNA gyrase by 
pyridonecarboxylic acids. In the first model, DNA gyrase may supercoil 
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or relax DNA at any site where it is bound, and the drug will prevent 
this "twisting" whenever it is in contact with the enzyme (Figure 37A). 
This inhibition would be uncompetitive and would only occur if drug-
bound DNA sites had no effect on the affinity and pattern of binding of 
DNA gyrase to DNA. Alternatively, DNA gyrase may only be able to 
supercoil or relax specific 11 twistable 11 sites on the DNA, and this is 
the basis of the second and third models. The site specific cleavage of 
DNA by DNA gyrase and the discovery of a full binding mode and an 
incomplete binding mode of DNA gyrase to DNA (34A) supports this 
assumption (22,59,74). In the absence of drug, DNA gyrase may 
translocate along the DNA molecule until it reaches a site that is 
twistable. In the second model, drug-bound sites on the DNA may block 
this translocation and prevent the enzyme from reaching a twistable site 
(Figure 378). In the third model, DNA gyrase may have a higher affinity 
for drug-bound sites than it does for twistable sites. The presence of 
enough drug bound sites wi 11 prevent the binding of DNA gyrase to 
twistable sites (Figure 37C). In the second and third models, 
pyridonecarboxyl ic acids would effect the association of enzyme and 
substrate; thus, the inhibition would be competitive. 
Cornish-Bowden plots of the inhibition of the relaxation reaction 
by pyridonecarboxylic acids indicate competitve inhibition at high 
substrate concentrations and uncompetitive inhibition at low. These 
results are in agreement with the third model. At high substrate 
concentrations, there will be less drug bound per unit length of DNA. 
Thus, not a 11 of the twi stable sites wi 11 be bound by drug and drug-
bound DNA sites will compete with unbound twistable sites for DNA 
gyrase. A DNA gyrase molecule which is trapped at a drug-bound DNA site 
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Figure 37. Three Models of Pyridonecarboxylic Acid Inhibition of the 
Pseudomonas aeruginosa DNA Gyrase Relaxation Reaction. 
E = Pseudomonas aeruginosa DNA gyrase, S = supercoiled DNA, S* = 
"twistable site, 11 D = pyridonecarboxylic acid. Double lines across the 
arrows represent an inhibition of the reaction. 
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which is not a twistable site is essentially inactivated. If one 
considers the drug-bound DNA and not the drug alone as the inhibitor, 
this type of inhibition is competitive. At low substrate 
concentrations, more drug will be bound per unit of length of DNA. At 
the substrate concentration when all of the twistable sites are bound by 
drug, the inhibition becomes uncompetitive. In uncompetitive 
inhibition, the inhibitor, which in this case is considered as the drug 
alone, binds to the enzyme substrate complex and not the free enzyme. 
In summary, the model for the inhibition of the DNA gyrase 
catalyzed relaxation reaction by pyridonecarboxylic acids is as follows. 
This drug will bind to DNA forming a drug-DNA complex that competes with 
unbound twistable DNA sites for DNA gyrase, thus resulting in a 
competitive type inhibition. As the drug concentration is increased (or 
the substrate concentration decreased), all of the twistable DNA sites 
will be bound by drug and the inhibition will become uncompetitive. 
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